Use of platelet rich plasma in tendons' and ligaments' injuries in sport horses by Ricciardi, Giulia
1 
  
 
 
 
 
Dottorato in Clinica e Terapia D‘Urgenza Veterinaria 
Ciclo XXIII 
Settore Scientifico Disciplinare Vet/09 
 
 
USE OF PLATELET RICH PLASMA IN 
TENDONS’ AND LIGAMENTS’ INJURIES 
IN SPORT HORSES 
 
 
 
 
 
Tesi di dottorato di: 
Dott. ssa Giulia Ricciardi 
 
 
Coordinatore:               Tutor: 
Chiar.mo Prof. Antonio       Chiar.mo Prof. Alessandro 
       Venturini       Spadari 
 
 
Esame finale anno 2011 
 
Alma Mater Studiorum Università di Bologna 
2 
  
USE OF PLATELET RICH PLASMA IN 
TENDONS’ AND LIGAMENTS’ INJURIES 
IN SPORT HORSES 
 
INTRODUCTION 
 
SECTION 1: Understanding bio-mechanical and functional features, 
injuring and healing processes of tendons and ligaments in the 
equine distal limb 
Chapter 1: Histology, morphology and functional anatomy of superficial digital 
flexor tendon, deep digital flexor tendon, inferior check ligament and 
suspensory ligament 
Histology and morphology of tendons 
 Specific structural differences and compositional features among tendons 
Anatomy 
 Superficial Digital Flexor Tendon 
 Deep Digital Flexor Tendon and Inferior Check Ligament 
 Suspensory Ligament 
Dorsal Digital Extensor Tendon 
Lateral Digital Extensor Tendon 
Vascularization of tendons 
Functional anatomy of tendons and Ligaments 
 
Chapter 2: Tendons’ and ligaments’ injuries in the equine distal limb 
Types of lesion 
 Straining 
3 
  
 Tendon ruptures 
 Transcutaneous tendon lesions 
SDFT tendonitis 
DDFT tendonitis 
ICL and SL desmitis 
Symptoms and diagnosis of tendons and ligaments injuries 
Collateral exams 
 Ultrasonography 
 
Chapter 3: Tendons’ and ligaments’ healing process 
The healing process 
The progressing of lesions: acute vs chronic, two different environments 
Therapy 
 Cold 
 Bandage 
 Stable confinement 
 Physiotherapy 
Pharmacological therapies 
Anti-inflammatory drugs 
Sodium hyaluronate 
Polysulphated glycosaminoglycans 
Beta-aminopropionitrile Fumarate 
Physical therapy 
 Laser therapy 
 Ultrasound 
 Ionizing Radiation 
 Magnetic Fields and Electricity 
Extracorporeal shock wave therapy 
4 
  
Surgical therapy 
 Tenorraphy 
 Splitting 
 Synthetic implants 
 Cauterization 
 Other surgical solutions 
Regenerative medicine 
 Implants 
 Stem cells 
 Growth factors 
 
 
SECTION 2: The role of platelets concentrates in tendons’ and 
ligaments’ healing process 
Chapter 1: Platelets 
Formation, composition, physiology and biological role of platelets 
 Platelets’ membrane 
 Platelets’ cytoplasm 
 Platelets’ granules 
 Platelets’ activation and adhesion 
 Platelets’ shape modification 
 Secretion 
 Aggregation 
Growth Factors 
 IGF-1 
 TGF-β 
 VEGF 
 PDGF 
5 
  
 
Chapter 2: Platelets’ concentrates 
PRP application in human medicine 
Use in odontoiatry and maxilla-facial surgery 
Use in plastic surgery 
Use for treatment of ulcers 
Use in orthopedic surgery 
Treatment of tendons and ligaments 
Use in ophthalmic surgery 
Potential risks of the use of PRP in human medicine 
Application of PRP in horses 
 Use in orthopedic surgery 
 Treatment of skin wounds 
 PRP in equine tenodesmic lesions 
Quantification of growth factors in PRP 
Platelet count 
Activation of PRP 
Methods for the preparation of PRP in equine medicine 
Role of WBCs in platelets concentrates 
Potential risks of the use of PRP in horses 
 
SECTION 3: Use of autologous platelet rich plasma for tendons’ and 
ligaments’ injuries in horses: a clinical trial 
Designation of a protocol for the preparation of autologous platelet rich plasma in horses 
 Preparation procedure 
 Injection 
 Follow up 
Clinical cases 
6 
  
 
Discussion 
Conclusions 
References 
  
7 
  
 
 
 
INTRODUCTION 
 
 
 
Tendons and ligament injuries in horses are a major problem for any kind of 
discipline and attitude, often demanding long periods of rest, introduction in 
lower classes of competition and sometimes retirement from the sport activity 
(Smith, 2008). The site of the lesion, the affected limb and the use of the horse 
are the main concerns in assessing the possibility of recovery and the prognosis 
(Ross & Dyson, 2006). Throughout the decades a number of possible therapies 
has been experimented yet none of them has ever turned out to be able to ensure 
a complete restoration of the anatomical and functional integrity of the injured 
tissue. In the past, effort has been put to improve the quality of the healing 
process of these tissues and the aim was to obtain a scar tissue enough strong 
and elastic to allow somehow the reintroduction to activity. Therapies, from stall 
rest to shock wave treatments, basically were trying to improve the process of 
reparation. Nowadays scientific research has brought to light the possibility to 
work on healing processes not in the sense of reparation but of regeneration. 
Regenerative medicine principles are based on the belief that healing processes 
cannot just be improved in a quality or timing side, yet they can be led to 
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produce matrix tissue other than scar tissue with the help of autologous blood 
derivatives and MSCs (Fortier & Smith, 2008). The regenerative properties of 
tissues are studied everyday more to understand to what point the regeneration 
can be led either with the implantation of cells to differentiate in the desired way 
or with the application of sources of growth factors to boost the tissue‘s own 
capability to regenerate. In this sense, platelets concentrates have been in the last 
decades addressed as possible proper solutions to the problem, being a 
substantial source of growth factors potentially boosting the reparative process 
and improving the quality of the heal (Borzini & Mazzucco, 2005). Nevertheless 
there is a general lack of knowledge about the precise indications, timing, 
number of applications and minimum number of platelets for the treatment and 
its effectiveness is yet to be clinically investigated. Too many are in fact the 
possible interactions of platelets‘ growth factors in the site of lesion and each 
one can affect the outcome of the healing process: each tissue has different 
healing features regarding the behaviour of cells after the injury in the sense of 
time for healing, environment, biochemical and physical interactions, not 
forgetting that the age, the characteristic of the lesion itself and the concomitant 
local and systemic situations play a role too (Weibich et al., 2002). All of these 
variables are hard to investigate for importance and far to be completely 
decoded at the moment for some tissues (as tendon, ligament and cartilage) 
more than for others (skin and bone). 
All over the world researchers have been working both in vitro and in vivo to 
gain as much knowledge as possible as the difference between a scar and a 
regenerated tissue is a fundamental topic in human medicine. In veterinary 
medicine preliminary studies have gained advantage from these researches and 
have later on faced the problem of having to deal with many different species. 
Skin and bone have been widely investigated from veterinary researchers for the 
importance of their lesions in dogs and much is the interest in understanding 
how these tissues can benefit from the development of regenerative medicine. 
Unfortunately for a number of reasons for horses it is quite different and the 
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tissues target of interest are necessarily tendons and ligaments; too little can in 
fact be done for bone major lesions in horses and, on the other hand, too little is 
usually the importance of skin lesions compared to the possible dramatic effect 
of an injured tendon or ligament on the activity of the horse. 
Laboratory research can point out some fundamentals to refine the treatments 
but in horses, more than in other species, the final assessment for use must pass 
by in vivo trials. In many countries, such as Italy, in vivo research on horses is 
nearby impossible to be performed, thus the closest way to approach the 
meaning of the leading of a biological process in one sense or the other is the 
clinical trial. Clinical trials are of great support to research but definitely lacking 
of some cornerstones of research. The application of treatments on large 
numbers of subjects could help to outline the guidelines for the effective and 
actual use of blood derivatives and stem cells. 
The present study was outlined as an answer to the need to create some 
guidelines for the application of autologous blood derivatives (i.e. PRP) in 
tendons and ligaments lesions in sport horses referred for lameness at the 
Veterinary Teaching Hospital of the Faculty of Veterinary Medicine of Alma 
Mater Studiorum – University of Bologna. The first step of the research focused 
on the preparation protocol to obtain a sort of internal ―standard of quality‖ of 
the product, whose aimed characteristics were pictured on the basis of updated 
literature. The second step consisted on the application of PRP obtained with the 
standardized protocol in those horses that had been assessed to have an injury 
either in the SDFT, or the DDFT, or the ICL or the SL both in front or hind 
limbs. Horses were followed for one year after treatment and the outcome was 
considered for results. Thus the aims of this study were to standardize a protocol 
of preparation for PRP and to verify the effectiveness of a PRP application in 
tendon and ligament spontaneous lesions in sport horses. 
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SECTION 1 
 
Understanding bio-mechanical and functional 
features, injuring and healing processes of 
tendons and ligaments in the equine distal limb 
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Chapter 1 
 
Histology, morphology and functional anatomy of superficial 
digital flexor tendon, deep digital flexor tendon, inferior check 
ligament and suspensory ligament 
 
 
 
The distinction between tendons and ligaments is substantially anatomical: 
tendons connect muscles to bones while ligament tie two bones to each other. 
Connecting a muscle to the bone, tendons are often erroneously considered inert 
structures involved in the movement of joints. It is though to be considered that, 
even if the function of maintenance of position is important, tendons have the 
fundamental role of storing kinetic energy and allow locomotion. This is 
especially true in horses where tendons of the palmar/plantar surface of the 
metacarpal/tarsal region (SDFT, DDFT) bear the stress of the hyper-extension of 
the fetlock joint in the stepping phase and release the energy during elevation. 
One of the differences between these structures that behave like springs and 
other tendons whose role is limited to maintenance of position (i.e. extensor 
tendon) is the stiffness of the structure, which is almost doubled in these last 
ones (Smith and Goodship, 2004). 
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HYSTOLOGY AND MORPHOLOGY OF TENDONS 
 
 
 
Tendons are tough strands of fibrous connective tissue having a role of 
―intermediate items‖ between a muscle and a bone. The dense connective tissue 
is organized in a regular pattern, with a peculiar spatial disposition responding to 
the bio-mechanical requirements of the tendon. Tendons are mainly composed 
of water (70%). The remaining 30% of dry mass includes mainly collagen and a 
―non-collagen‖ matrix (Dowling et al., 2000). 
Water is fundamental to ensure the elastic properties to the tissue. Density of 
tendons increases when dehydration occurs causing a loss of elastic properties 
(Smith and Goodship, 2004). 
In the past the fibrils of collagen were considered the major responsible for the 
strength of the tendon; the intra-and inter-fibrillar covalent bonds of collagen 
though and the electrostatic bonds of non-collagen proteins have recently been 
demonstrated to have greater importance in giving the tendons their bio-
mechanical features (Dowling et al., 2000). 
Tenocytes are displayed in long parallel rows in the spaces among collagen 
fibers. On the basis of the nuclear morphology three different types of cells (I, 
II, III) have been identified in the tendinous fascicles. A fourth type of cells has 
been recognized instead inside the endotenon (Smith and Goodship, 2004). The 
distribution of the cellular types varies among tendons and within the same 
tendon depending on the age. The specific features of these different cells is not 
yet well known even though it is clear that type I and III cells have a higher 
metabolic activity as their nuclei are larger and richer in nucleoli. These cells 
may be primarily involved in the synthesis of the extra-cellular matrix (Dowling 
et al., 2000). 
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Tenocytes have numerous cytoplasmic ramifications connecting close cells 
through gap junctions. The deriving syncytium creates a transduction system 
similar to that created by osteocytes in bones (Smith and Goodship, 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tendon Structure (Dowling et al., 2000) 
 
Type I collagen is the prevalent type of collagen in normal tendons. Every 
molecule of type I collagen is assembled inside the endo-plasmatic net of the 
cell starting from a procollagenic molecule. This last one is made of two alpha-1 
chains and one alpha-2 chain that create a triple helix along with the terminal –N 
and –C domains. The pro-collagen molecule is cleaved by specific proteases 
cutting the terminal peptides and producing a molecule of tropocollagen. These 
molecules are then rearranged in a regular pattern to obtain insoluble collagen 
fibrils. Each collagen fibril overlaps with the next one for one fourth of their 
length. The fibrils are tight together by covalent bonds between the residues of 
lysine/hydroxyl-lysine of adjacent fibrils (Smith and Goodship, 2004). The 
fibrils then assemble further to form fascicles , and finally into a tendon fiber. 
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Groups of fascicles are bounded by the epitendon and peritendon to form the 
tendon organ. 
Type II, III, IV and V collagens are minor components confined in specific sites. 
Type II collagen is allocated at insertions and in the regions where the tendon 
changes direction around a bony spike. In these areas the fibro-cartilaginous 
nature of the matrix is enhanced with the aim to withhold the forces of 
compression and tension that the tendon undergoes. Type III, IV and V 
collagens are confined close to the basal membranes and to the endotenon 
(Dowling et al., 2000). 
Collagen is organized in tough parallel arrays closely packed together and 
disposed longitudinally. Collagen fibrils and fibroblasts are the basic structure of 
a tendon, representing the primary unit of a tendinous fascicle. Primary fascicles 
are assembled in secondary fascicle, furthermore arranged in tertiary fascicles. 
Collagen fibrils within the primary fascicle are parallel yet are disposed in a 
helix figure for the whole length of the tendon. The fasces of tendon fibrils are 
held together in an waved display (crimp pattern) on the surface. The crimping 
is only histologically visible in longitudinal sections of the tendon. 
The complex structure of the collagen fasces leads to a profound lateral cohesion 
within the tendon that obstacles, together with the inter-fibrillar fundamental 
matrix, fibers to skim among them. The crimp pattern plays a fundamental role 
for the elastic features of the tendon during the first phase of weight charge. The 
stress strain curve correlates the shrinking of the tendon with the stress to which 
it undergoes. Moderate forces cause the shrinking of the tendon with the 
flattening of the crimps while stronger pulling forces may cause the rupture of 
the fibers (Smith and Goodship, 2004). 
In young animals the angle within the crimps is of about 19°-20°and each crimp 
is extended for 17-19 mm in the central region of the metacarpus in the SDFT. 
In older subjects the angle is reduced to 12°-17° and the crimp to 11-15 mm. 
The reduction of the crimps contributes to the increase of stiffness proper of the 
aging process (Dowling et al., 2000). 
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The 20% of dry mass of a tendon is made of protein different from collagen. 
Despite the small presence they are fundamental for the structure and the 
function of the tendon itself (Smith and Goodship, 2004). 
Among glycoproteins the COMP (cartilage oligomeric matrix protein) is the 
most represented. The level of COMP at birth is low and it increases with age 
cumulating within the flexor tendons and reaching its highest level with the 
skeletal maturity of the horse (about 2 years of age). After the developing period 
its levels start to decrease again. COMP is mainly stored in those tendons which 
bear a lot of weight and harsh pulling forces (i.e. digital flexor tendons) other 
than in tendons which are less stressed (i.e. digital extensor tendons). The 
COMP storing process during growth makes the tendon stronger. The function 
of the COMP is not yet completely determined yet it is known that it binds the 
fibrillar collagens (including type I) with a Zinc-related mechanism. This 
interaction with collagen takes place thanks to the  C globular terminal domains 
of the COMP with 4 analogue places displayed along the collagen molecule. 
The COMP cannot occupy two spaces with only one domain, yet it can bind 5 
molecules of collagen, sorting them to form a fibril during the initial phases of 
formation of collagen (Smith and Goodship, 2004). If the COMP does not bind 
the collagen fibrils it is taken away. Recent studies have shown how the COMP 
accelerates the genesis of collagen fibrils in vitro and it is possible that this 
protein acted more as a building manager other than having a structural role. 
This would explain the higher concentration of COMP during growth that is 
when the synthesis of the matrix takes place (Smith and Goodship, 2004). 
Proteoglycans are made of two lateral chains of glycosaminoglycan connected to 
a central protein. Proteoglycans are divided in two different classes: large and 
small. Large proteoglycans have numerous lateral sulfate chains binding water. 
These molecules are majorly present in those sites where the tendon undergoes 
compressive forces. Small proteoglycans are thought to take part in the 
regulation of the diameter of collagen fibrils (Smith and Goodship, 2004). 
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Among horse SDFT‘s proteoglycans condroitin-sulfate, dermatan-sulfate, 
cheratan-sulfate, heparin and sulfate heparin, and ialuronic acid have been 
identified (Dowling et al., 2000). 
 
 
Specific structural differences and compositional features among tendons 
 
Among tendons there are differences in the content of water, collagen and other 
proteins. These compositional features reflect the diverse functions each tendon 
is aimed to (Smith and Goodship, 2004). 
Tendons can be divided in weight bearing structures, which act like springs, and 
in steady positioning structures, responsible for the maintenance of position of 
the skeleton. The first ones are less rigid and more elastic compared to the 
second ones which must be very stiff (Davis and Smith, 2006). 
Digital flexor tendons, which are weight bearing, have a higher percentage of 
water and less collagen compared to the extensor tendons, which are positioning 
tendons. Another compositional difference regards the COMP: at birth its level 
is low in all tendons increasing with aging ten times in flexor tendons, whereas 
in the digital extensor tendons its level does not change (Smith and Goodship, 
2004). The DDFT has lower levels of COMP compared to the SDFT and its 
collagen fibrils are large (in SDFT the fibrils are both large and small) (Davis 
and Smith, 2006). 
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ANATOMY 
 
 
 
In this study PRP has been applied in some tendons and ligaments of the distal 
part of the limb in horses. To understand the characteristics of the injection site 
it is necessary to provide a brief description of histology, morphology, anatomy 
and biomechanics of the structures where PRP was applied. Digital extensor 
tendons are mentioned whereas they have not been submitted to any application: 
the aim of the description is to highlight the peculiar functional and structural 
features of flexor tendons. 
In horses the muscular part of flexors in fore and hind limbs is well represented 
until the carpus and the tarsus respectively; distally to these only the tendon part 
can be found. The anatomy of the tendinous portion of flexors in hand and foot 
is nearly the same. 
The superficial digital flexor tendon (SDFT), the deep digital flexor tendon 
(DDFT) and the suspensory ligament (SL) are the three major structures 
counteracting the hyperextension forces stressing the fetlock joint on the 
palmar/plantar aspect of the distal part of equine limbs. At the dorsal aspect of 
the limb in the same regions there are the digital extensor tendons only 
responsible for the extension of the limb at walk. The proper functioning of a 
tendon requires its possibility to skim smoothly among surrounding tissues. In 
those areas where the tendon direction is suddenly changed, which mainly is 
nearby joints, the tendon itself is wrapped by a tendon sheath. This structure 
reduces the frictions between tendons and other structures like retinacula 
(McIlwraith, 2002). 
The tendon sheath is a compound of connective tissue layers both parietal and 
visceral, covered by synovial cells and forming a closed environment filled with 
synovial fluid. 
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The palmar aspect of the synovial sheath (called great sesamoidean sheath) 
presents two annular ligaments: the palmar annular ligament (PAL) and the 
digital proximal annular ligament (DPAL). The PAL is attached to the abaxial-
palmar aspect of proximal sesamoid bones. The PAL is a strong transverse 
ligament embracing the sheath and the flexor tendons, forming a canal along 
with the proximal scutum (proximal sesamoid bones and palmar ligament). The 
DPAL is a squared thin layer of connective tissue laying between the skin and 
the SDFT. Distally it is attached, along with the SDFT, to the first phalanx. The 
dorsal aspect of the sheath is formed by the palmar aspect of the inter-
sesamoidean ligament, the distal sesamoid ligaments, the scutum medium (thin 
fibro-cartilage layer attached to the second phalanx) and the second phalanx 
itself. 
The sheath is extended for 4-7 cm proximally to sesamoid bones and distally to 
the mid second phalanx. The sheath has many pouches: proximal, collaterals and 
distal. 
The proximal pouch of the sheath is in the distal part of the metacarpus, just 
proximally to the manica flexoria and the PAL. The collaterals are on the lateral 
and medial aspects of the first phalanx, between the flexors and the sesamoidean 
distal ligaments. The distal pouch is between the second phalanx and the dorsal 
aspect of the DDFT, separated from the proximal pouches of the podothrochlear 
bursa and the pouches of the distal inter-phalangeal joint by a thin layer of 
connective tissue. 
The DPAL adheres to the palmar aspect of the distal part of the DDFT and 
wraps the terminal expansion of the tendon. The ligament is formed of a fibrous 
layer tightened to a strong fascia which covers the distal tract of the SDFT 
(Denoix, 1994). 
A synovial bursa is similar to a tendon sheath yet it covers only a part of the 
circumference of the tendon. It is usually found where tendons pass on bony 
spikes. Along the straight course of the tendons, where a tendon sheath is not 
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necessary, surrounding tissue is composed by soft connective tissue and called 
peritendon, which is elastic and full of blood vessels. 
Despite the role of protection from traumas the sheaths have toward tendons, 
they also slow the healing process of tendons themselves. This action is due to 
the synovial fluid and to the absence of the peritendon. The peritendon is in fact 
considered the source of fibroblasts which are essential to the healing of tissues 
(McIlwraith, 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
Anatomy of the distal part of the limb (Smith et al., 2002) 
 
 
Superficial digital flexor tendon (SDFT) 
 
The superficial digital flexor muscle has a small muscular portion with 
numerous and strong tendon attachments. Its origin is on the upper part of 
medial epicondyle of the humerus, either directly or by a tiny tendon, often 
merging with one of the near muscles (medial ulnar muscle) (Denoix, 1994). 
The tendon takes shape in the distal part of the radius and receives, nearby its 
origin, a stiff fibrous structure called superior check ligament (SCL or SDFT 
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accessory ligament), which origins from the palmar aspect of the radius. In this 
area the tendon has circular or prismatic shape; distally the tendon enters the 
carpal canal and going through it is on the medial-palmar aspect of the DDFT. 
At the proximal part of the metacarpus the tendon flattens to assume the shape 
of half moon, embracing in its concavity the DDFT. Just above the proximal 
sesamoid bones it forms a ring (manica flexoria) through which the DDFT 
passes. This ring though doesn‘t extend more than to the median part of 
sesamoid bones. The SDFT is afterwards the most superficial structure until the 
distal part of the first phalanx where is splits into two stiff and short branches 
attaching to the extremity of the glenoid cartilage of the second phalanx. 
In hind limbs the superficial digital flexor muscle‘s carny portion is small and 
merged with abundant fibrous tissue, having the shape of a rope and extending 
from the femur (supracondylar fossa) to the second phalanx. The tendon flattens 
in the calcaneal region where its shield skims over a large synovial bursa, 
reassuming its ropy shape at the palmar aspect of the metatarsus. Its stiff, 
fibrotic structure and reduced elastic properties allow the tendon to strongly 
contribute to the keeping of correct angulation of the hock and fetlock joints. 
 
 
Deep digital flexor tendon (DDFT) and inferior check ligament (ICL) 
 
The deep digital flexor muscle has three heads. One originates from the 
humerus, one on the palmar aspect of the proximal side of the radius, one on the 
proximal side of the ulna (medial aspect of the olecranon). The heads are quite 
different in dimension, being the humeral one the strongest, thickest and 
prismatic. It has a large tendinous component which can be easily spread in 
many fasces, which collect distally to form a bulky tendon. The ulnar head has a 
pyramidal short carny part and its tendon runs distally in vertical direction 
between the two ulnar muscles. The radial head is the shortest and thinnest, 
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becoming distally a small, flat tendon merging to the superior check ligament 
and reaching later on the humeral head, in the radius-carpal joint area. 
The tendon common to the three heads (DDFT) seems to be the direct 
prosecution of the humeral head; it runs through the carpal canal along with the 
SDFT in a deeper position. Half the way along the metacarpus it receives the 
inferior check ligament. The inferior check ligament (ICL) is a stiff and strong 
fibrous strand which prolongs the common palmar ligament of the carpus. Its 
proximal insertion is on the most proximal palmar aspect of the metacarpus and 
it is wide and thick, with rectangular shape. Running distally the ICL becomes 
thinner and narrower, merging to the DDFT on its dorsal aspect (Denoix, 1994). 
Behind the metacarpus-phalangeal joint the DDFT runs through the manica 
flexoria being hidden by the distal part of the SDFT until the pastern joint. In 
correspondence of the proximal scutum it becomes larger, elliptic and fibro-
cartilaginous. At the proximal half of the proximal pastern the DDFT is divided 
into two symmetric cylindrical parts and its fibers assume a spring-like 
disposition. Both parts decrease in width and thickness running distally. The 
smallest cross sectional area (CSA) of the DDFT is found at the level of the half 
of the proximal phalanx where the tendon passes through the two terminal 
branches of the SDFT becoming superficial. At the distal half of the first 
phalanx the CSA of the DDFT increases. In correspondence of the upper part of 
the second phalanx  the dorsal aspect of the tendon presents a fibro-cartilage 
thickening. Running distally, passed the palmar aspect of the navicular bone, the 
DDFT widens in a fan shape of cartilaginous nature; the palmar aponeurosis 
occupies the whole space between the lateral and medial palmar processes of the 
coffin bone. It is attached to the cresta semilunaris of the third phalanx and it is 
kept in site by a strong reinforcement fascia (Denoix, 1994). 
In hind limbs the deep digital flexor muscle derives by the merging of the lateral 
digital flexor muscle and the medial digital flexor muscle. The lateral flexor is 
quite strong, its carny portion is thick and first prismatic, then cone-shaped in its 
distal part. It presents many fibrous laminas and is wrapped by a solid 
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aponeurosis. The tendon has an oval section, becoming independent at the 
foremost distal part of the tibia and receives the tendon of the tibial caudal 
muscle in the tarsal area. It continues in the tarsal sheath where it is wrapped by 
a large synovial bursa with a proximal pouch projected upward along the plantar 
aspect of the tibia, while the distal pouch goes down until the mid metatarsus. 
The medial digital flexor muscle has a thin fusiform carny portion. The tendon is 
of cylindroid shape and origins around the distal third of the tibia, passes 
through the malleolar canal and afterwards through a sheath formed by the tarsal 
medial collateral ligament and the plantar fascia. The tendon crosses caudally 
the surface of the proximal extremity of the medial metatarsal bone and reaches, 
forming an acute angle, the tendon of the lateral flexor at the mid metatarsus. 
Starting from this point the DDFT receives the superior check ligament, which 
arrives from the distal plantar ligament of the tarsus. Distally to this the anatomy 
is similar to the forelimb. 
 
 
Suspensory ligament (SL) 
 
The suspensory ligament (SL) originally derives from a muscle and it still 
contains some muscular fibers both in the proximal portion and the mid body. 
The muscular portion is well represented in the fetus and in young animals, 
whereas in adults the fibrous component takes over. The SL can be considered 
as a structure where the tendinous component is substituted by muscular fibers, 
it is yet classified as a ligament because of its cell morphology and the lack of a 
muscular body properly called. 
The SL is a long, tough and strong strand extending from the upper part of the 
palmar aspect of the metacarpus to the sesamoid bones, between the metacarpus 
and the flexor tendons. 
In the distal third of the metacarpus it branches in two, forming an acute angle. 
Both branches are tightly inserted on the apex and abaxial aspect of the 
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corresponding sesamoid bone (medial/lateral), and extending further distally 
with a stiff fibrotic branch which reaches the digital dorsal extensor, embracing 
the proximal pastern, and attaching with the extensor at the coffin bone (Dyson 
et al., 1995). 
In clinical practice the SL is divided in three parts: proximal, mid-body and 
branches (Dyson and Genovese, 2003). 
 
 
Dorsal digital extensor tendon 
 
The muscular part of the dorsal digital extensor muscle has its proximal 
insertion on the distal edge of the epicondyle crest and at the basis of the lateral 
condyle of the humerus. It becomes a tendon in the distal third of the radius after 
dividing in two unequal parts. The strongest of the two represents the digital 
extensor properly called and its distal attachment is provided by a long and stiff 
tendon running on the dorsal aspect of the carpus and provided with its own 
synovial membrane. The tendon spreads in the fetlock region and is there 
provided with a sub-tendinous bursa for correct skimming. Further distally it 
spreads and flattens even more becoming thicker in correspondence of the dorsal 
aspect of the phalanxes. By the distal edge of the first phalanx it receives the 
branches of the SL. Its distal insertion is on the pyramidal eminence of the third 
phalanx. The second part of the muscle is much smaller and it is lateral to the 
other part. It continues with a thin tendon which passes in the same bursa on the 
dorsal aspect of the carpus with the large tendon and bends afterwards with an 
acute angle to reach the lateral digital extensor. This thin tendon is although 
often found on its own running distally to the proximal pastern forming with the 
tiny muscular part to which it belongs the Philips muscle (Barone, 2004). 
In hind limbs the dorsal digital extensor muscle‘s proximal insertion is in the 
homonymous femoral fossa, between the trochlear lateral ridge and the lateral 
condyle, through a small tendon. It continues with a muscular fusiform body, 
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flattened in dorso-plantar direction and covered by an aponeurotic membrane 
which becomes thinner running distally. The tendon that afterwards originates 
begins in the distal fourth of the tibia with a cylindrical shape, flattening as it 
passes in front of the tarsus, the metatarsus and the phalanxes. In the tarsal 
region it runs under the three extensors‘ retinacula (proximal, mid and distal) 
being wrapped in the same area by a long and narrow synovial membrane. It is 
reached by the lateral digital extensor tendon as it runs by the dorsal aspect of 
the fetlock. The distal anatomy is comparable to the fore limb (Barone, 2004). 
 
 
Lateral digital extensor tendon 
 
The lateral digital extensor muscle has a thin muscular body that originates from 
the proximal lateral tuberosity of the radius and from the edge between radius 
and ulna. Its tendon runs on the dorsal aspect of the radius becoming 
independent by the distal third of the forearm and, passed the carpus, it folds 
toward the dorsal lateral aspect of the third metacarpal bone. It receives a tough 
branch from the pisiformis bone and the ending of the tendon of Philips. It 
extends then on the dorsal aspect of the fetlock and ends on the proximal edge of 
the proximal pastern (Barone, 2004). 
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VASCULARIZATION OF TENDONS 
 
 
 
Tendons receive blood supply from four sources: from the muscle, from the 
bone it attaches to, from the mesotendon layer (vinculum) inside the synovial 
sheath and from the peritendon where there is no sheath (McIlwrhaith, 2002). 
The tendon matrix, inside the sheaths, can be moreover nourished by the 
synovial fluid for diffusion (Davis and Smith, 2006). 
The blood supply deriving from these sources varies in its extent depending on 
the tendon and the side of the tendon. In the metacarpal region, for example, the 
SDFT mainly receives blood supply by the proximal muscle-tendon junction 
(Smith and Goodship, 2004). 
It has been demonstrated that the muscle and the bone supply blood only to the 
proximal and distal 25% of a tendon thus it can be assumed the paratendon layer 
to play an important role. In a few studies about equine forelimb have shown 
that proximally and distally the SDFT and the DDFT receive blood vessels from 
their respective muscle of derivation and from their insertions on the bones. 
Within the carpal sheath the principal branches of the median artery give 
vascularization to the surface of these tendons through the mesotendon; other 
branches run parallel to the flexor tendons along the metacarpal bone 
(McIlwraith, 2002). 
Between the carpal sheath and the digital sheath tendons are wrapped by the 
peritendon layer through which blood vessels enter the tendons themselves. 
The SDFT receives blood supply by various arteries. One artery derives from 
the median artery and reaches the tendon in correspondence of the muscle-
tendon junction. Close to the proximal edge of the PAL the tendon receives an 
artery from each side (lateral/medial metacarpal distal branch) which originates 
from the corresponding digital artery. Nearby the distal edge of the PAL the 
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tendon receives again a vessel branch (digital proximal) deriving from the 
corresponding digital artery. All of these branches give supply to a wide intra-
tendinous vascular net made of arterioles placed longitudinally along and among 
the fasces of fibers and that generate numerous anastomoses among themselves 
with perpendicular branches (Denoix, 1994). 
The DDFT is supplied by three sources of blood. Proximally to the fetlock 
region the tendon receives a branch either from the second common palmar 
digital artery or the third common palmar digital artery. This branch enters the 
synovial sheath in correspondence of the proximal pouch and runs distally on 
the palmar surface of the tendon. Distally to the fetlock, by the mid first 
phalanx, the palmar branches of the proximal phalanx (which originate from the 
lateral and medial digital artery) give origin to one or two branches which reach 
the dorsal aspect of the tendon. The foremost end of the tendon is nourished by 
two small arteries originating from the lateral and medial digital arteries. 
These blood vessels build an intra-tendinous vascular net within the DDFT other 
than in the region of the fetlock: in this area the vessels are confined to the 
palmar surface of the tendon (Denoix, 1994; Hay Kraus et al., 1995). Some 
nourishment is guaranteed by the synovial fluid of the digital sheath, and it 
reaches the tendon for diffusion. 
The lack of vascularization of some portions of tendons has been related to a 
predisposition to the development of degenerative diseases and to tendinitis 
(McIlwraith, 2002), yet the DDFT presents some histologic adaptation features 
to this closely ischemic environment: it presents in fact, in the fetlock area, a 
little number of cells and a high quantity of fibro-cartilaginous matrix. The 
proteoglycans of the cartilage allow the movement of the synovial fluid during 
the cyclic compressions favoring the passage of nutritive substances to the less 
vascularized parts. Recent studies have moreover shown the greater resistance of 
tenocytes compared to other types of cells to survive in situations of relative 
hypoxia, where they are able to keep their proliferative activity. Furthermore 
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studies on other species have excluded an alteration of the vascularization as 
possible primary cause of tendinitis (Smith, 2003). 
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FUNCTIONAL ANATOMY OF TENDONS AND 
LIGAMENTS 
 
 
 
Tendons and ligaments have similar histological and biochemical features yet 
have different biomechanical importance. Tendons actively transfer the weight 
charge from the muscle to the bone, being thus ―power transducers.‖ They own 
a great resistance to tension and have relatively scarce extensibility. Ligaments 
instead resist passively to the charge. 
Flexor and extensor tendons may act either independently to bend or extend 
digital joints or together to give stability to joints. In horses during locomotion 
flexor tendons are responsible for bending the digit when the limb is lifted and 
for supporting the fetlock in the stepping phase. In this phase elastic energy is 
stored by flexors to be released in the following step, thus reducing the energy 
required and increasing the efficiency of the locomotion system. When 
galloping the fetlock is hyperextended and flexor tendons and the suspensory 
ligament undergo huge pulling forces that stretch them to the limit of rupture. In 
the majority of homogeneous substances there is a linear correlation between 
applied force and deformation that can be expressed by an elastic constant; 
tendons instead respond with a non-linear deformation to the charge. At the 
beginning there is a great stretching for small increments in the charge which is 
followed by a phase of linear correlation between increasing of charge and 
stretching (Goodship and Birch, 1996). 
In a mono-directional extension the tendon appears yielding to the pulling 
forces; with an increase of the pulling although there is a stiffer response. In this 
transitional phase the crimp pattern disappears. To see the straitening though the 
tendon must be extended at least of the 3% of its length. 
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Riemersma et al. ran a study on 5 ponies and demonstrated that the lengthening 
of the SDFT, the DDFT and the SL increases a lot along with the speed of gait. 
At walk the lengthening is of 2.19%, 1.15%, and 3.36% respectively, while at 
trot they are of 4.15%, 1.70%, and 5.78% (Riesmersma et al., 1996). 
When the pulling force stops the crimp pattern returns. After this phase of initial 
elastic response the mechanic characteristics of the tendon change and become 
viscoelastic. When submitted to a constant charge the tendon extends 
progressively in time. The biomechanical behavior of a tendon submitted to a 
force is represented by a stress-strain curve (Smith and Webbon, 1996). 
 
 
Stress-strain curves 
 
In the stress-strain curve the percentage of lengthening (strain) is put in relation 
with the applied force per space unit (stress). The obtained curves are different 
for each tendon and part of the tendon. 
The curve can be divided in three regions (phases): 
1-initial part (elastic phase): there is a non-linear lengthening of the 
tendon; this condition is related to the flattening of the crimp pattern; 
2-intermediate part (viscoelastic phase): there is a linear deformation of 
the tendon; in this part of the curve the elasticity of the tendon itself is 
determined 
3-final part (rupture phase): the curve slumps to the 0 point; this phase 
corresponds to the rupture of the bonds among collagen fasces or to the rupture 
of whole fibrils (Smith and Webbon, 1996). 
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Stress-strain curve (Dowling et al., 2000) 
 
 
 
Biomechanical parameters 
 
From the stress-strain curve some biomechanical parameters can be drawn: 
 Final straining power (% of extension of the tendon at the rupture point). 
Abrahams states that the limit for the lengthening of a tendon is about 5%. 
Herrich et al. performed in vitro studies applying cyclic compressions on 
normal SDFT specimen observing that equine flexor tendons can stretch 
up to the 10-12% without rupturing. Crevier et al., also with in vitro 
studies, obtained quite inconstant responses for SDFT rupture point, 
varying between 8.1% and 12.5% of stretching. The lowest values were 
recorded for the fetlock region and the highest for the metacarpal portions 
(Crevier et al., 1996). In Warmblood gallopers the possible stretching of 
the SDFT has been demonstrated to be up to the 16%. This datum shows 
how the tendon can be functional to the limit of its straining power. 
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 Final tension power (force/unit of space where the tendon ruptures). 
 Elasticity module 
 
 
Conditioning and hysteresis 
 
The visco-elastic properties of a tendon are represented by the shifting of the 
stress-strain curve from left to right. Repeated charges cause a shifting of the 
curve to the left, thus an increase in the stiffness of the tendon: this process is 
called ―conditioning.‖ 
Another known property of the tendon is called ―hysteresis.‖ This one is 
represented by the difference between the charge curve and the discharge curve. 
The difference between the area under the curves represents the energy ―lost‖ by 
the tendon (that in horses is about 5%) during the charging cycle. Part of this 
energy is responsible for the increase of temperature of the tendon. This 
phenomenon is associated to repeated stresses and time, and is thought to be a 
cause for the development of tendonitis in the SDFT. The tendon is quite 
resistant though to this physical process and tenocytes are not damaged by high 
temperatures. Thus the tendon shows much more complex biomechanical 
properties than a normal elastic substance (Smith and Webbon, 1996). 
In flexor tendons the cross sectional area changes along its length. There is 
obviously also a great variability among horses as it is related to height, weight, 
and metacarpal circumference of the horse. Riemersma et al. have demonstrated 
that a tendon under charge stretches homogeneously. They also showed that the 
elasticity module is inversely proportional to the content of collagen. They 
deduced that the final stretching strength is inversely proportional to the cross 
sectional area while elasticity is quite constant along the whole length of the 
tendon (Crevier et al., 1996). The SDFT is a quite homogeneous tendon, yet in 
the metacarpal region its proportional content of collagen (responsible for a 
greater elasticity) is higher than in other parts of the tendon. In any way this 
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stronger structure of the tendon is not capable to compensate the reduced cross 
sectional area owned at this level. In the metacarpal region infact the SDFT is 
more often injured both in vivo and in vitro (Crevier et al., 1996). 
The age of the animal also affects the biomechanical properties of tendons and 
ligaments. Wilmink et al. demonstrated how the angles of the crimps in the mid 
portion of tendons of adults were reduced compared to those of the younger. 
Thus adult subjects resulted more likely to develop tendon straining (Smith and 
Webbon, 1996). 
  
33 
  
 
Chapter 2 
 
Tendons‘ and ligaments‘ injuries in the equine distal limb 
 
 
 
In horses the tendons of the distal limb are subjected to exogenous and 
endogenous traumas. Exogenous traumas are usually wounds and contusions. 
Wounds caused by foreign bodies often sever completely the tendon and are 
accompanied by septic contamination. In contusions instead the physical injury 
to the local vascular net provokes a blood effusion which causes the edema and 
triggers the inflammation process. 
Endogenous traumas are much more frequent and various: they are roughly 
called strains (stretching of the tendon beyond its physiologic length range) and 
can vary a lot in their seriousness. Minor strains are often subclinical, featured 
by a partial rupture of a portion of the tendon or of only a part of the fibrils. In 
severe strains the amount of ruptured fibrils increases up to get to the complete 
rupture in the cross sectional area. The fibrillar architecture is at this point 
completely destroyed. 
Also SL stress injuries are classified as strains, as this structure is the relic of the 
III interosseous muscle and not a ligament properly called (McIlwraith, 2002). 
The following inflammation is called tendonitis. In horses the word tendonitis is 
correctly used to refer to the inflammation following a strain and involving the 
portion of tendon surrounded by the peritendon and not by the tendon sheath. 
The word tendo-synovitis refers instead to the inflammation of the part of 
tendon wrapped by the sheath, while the tenosynovitis is the inflammation of the 
only tendon sheath. The inflammation of a ligament is called desmitis. 
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There can be a thickening close to the lesion as a result of a fibrosis process of 
the tendon, of the surrounding peritendon and eventually of the tendon sheath. 
This thickening is usually visible as a palmar/plantar swelling of the SDFT. The 
tendinitis of flexor tendons has also been classified on the basis of the site 
(Watkins et al., 1985 A): 
-proximal: right under the carpus or the tarsus 
-mid: in the mid third of the metacarpus or the metatarsus 
-distal: in the distal third of the metacarpus or metatarsus and in the region of the 
PAL. The DDFT can also be involved distally to the fetlock joint. This lesion is 
described as low tendonitis. 
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TYPES OF LESION 
 
 
 
Straining 
 
A tendon strain can occur when the tendon is suddenly loaded with a charge 
greater than its tensile resistance. Any change in the structural features of the 
tendon can‘t be considered positively because tendons already always work to 
their limit of resistance. Thus when it is overloaded a mechanic disruption of 
tendon matrix occurs predisposing the tendon itself to develop tendonitis. 
This probably is the mechanism that most frequently turns out in ligament 
injuries and some DDFT injuries (Davis and Smith, 2006). The most common 
lesions caused by straining involve the structures of the palmar aspect of the 
metacarpal region and the clinically evident lesion is probably often preceded by 
a phase of molecular degeneration. 
Degeneration is usually the first phase of a tendinopathy. A pure degenerative 
process does not induce either a clinically evident inflammatory response or a 
healing process, yet it does likewise contribute to the weakening of tendon 
structure (Davis and Smith, 2006). Running speed during sport activity and 
some predisposing factors play a fundamental role in the development of a 
strain. 
Many causes have been hypothesized to predispose to such injuries like impair 
training, muscular fatigue and rapidly repeated stresses (Dowling et al., 2000). 
An abnormal conformation or angulation of the fetlock joint , caused either by 
muscular flaccidity or developmental defects, also increases the stresses on the 
tendon; likewise do an excessive sloping angle of the pastern, incorrect shoeing, 
and untrimmed hoof tips. Other concurrent factors may be: incoordination and 
disproportion between body weight and tendon resistance, training on irregular 
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or slippery soil, training on short turns courses where the tendon is solicited 
more on one side than on the other (Davis and Smith, 2006). 
 
 
Tendon ruptures 
 
The mechanism through which tendon and ligament ruptures happen within a 
synovial sheath is nowadays not completely clear. The structures that are more 
often damaged are the DDFT (especially in forelimbs) and the manica flexoria 
(especially in hind limbs). DDFT lesions are mainly caused by excessive 
stretching and usually occur by the its lateral edge, where the tendon folds 
cranially downwards, beyond the fetlock. Many ruptures of the manica flexoria 
are found instead after long lasting tenosynovitis, thus it is possible that the 
hypertrophy of the synovial layers, reducing the space for the skimming of the 
tendon, increases the chances for the ring to break up (Davis and Smith, 2006). 
 
 
Transcutaneous tendon lesions 
 
In horses, in the distal part of limbs, tendons are easily subjected to traumas as 
they are only covered by a thin layer of skin. The worst consequences possible 
occur when the palmar/plantar aspect is involved. A tendon can be severed for 
more than 50% of its cross sectional area and still be functioning at walk. 
Complete severing of the extensor tendon on the dorsal aspect of the limb 
seldom causes long term functional impairment (Davis and Smith, 2006). 
  
37 
  
SDFT TENDONITIS 
 
 
 
SDFT lesions seriously compromise a horse‘s sport performances, to the point 
of having to retire the horse from the activity. SDFT in horses is a charge 
tendon, quite similar in its function and structure to Achilles‘s tendon in 
humans. It is very often subject of injuries, up to the point that 93% of tendon 
and ligament lesions in horses have been estimated to affect the SDFT (Ely et 
al., 2004). 
In trotting horses the incidence of SDFT injuries ranges between the 7% and 
43% depending on the studies and forelimbs are mainly affected. The problem is 
often bilateral with a prevalence in the left limb. 
Racehorses are considered the ones with the highest risk of SDFT damage as 
they either run at high speed or run and jump (steeplechase) at the same time. 
SDFT is loaded with charge especially in the first phase of the step and the 
major stress is put in the landing phase after jumping (McIlwraith, 2002). SDFT 
lesions occur instead less frequently in dressage horses, Arabians, Quarter 
Horses and fox hunting horses. Nevertheless spontaneous SDFT lesions are 
found also in sedentary and untrained horses older than 15 years old. These 
lesions are often very severe and mainly involve the proximal portion of the 
tendon, in the proximal metacarpal, the carpal or the musculo-tendinous junction 
area (Jorgensen and Genovese, 2003). 
Sport activity related SDFT lesions occur most commonly in the mid third of the 
metacarpus, yet they may also affect any other portion of the tendon. In hind 
limbs the most affected part of the tendon is by the plantar aspect of the hock, 
and occasionally the lesion may involve the mid metatarsal portion (Jorgensen 
and Genovese, 2003). 
38 
  
Some authors advocate the development of degenerative changes in the tendon 
structure as preceding and predisposing to the rupture. This theory is confirmed 
by the fact that histologic evaluations of tendons of clinically normal racehorses 
showed the presence of numerous structural alterations. These changes are 
generally limited to the portion of tendon covered by the peritendon layer (mid 
metacarpal region) where the tendon has the thinnest diameter and the 
intratendinous vascularization is believed to be relatively lacking. Lesions 
generally develop symmetrically and bilaterally. They are initially identified in 
the center of the tendon and include a reduced formation of fibrous tendon 
fasces, degeneration and death of tenocytes (Smith, 2003). 
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DDFT TENDONITIS 
 
 
 
DDFT tendonitis are less frequent than SDFT‘s. An explanation for this to 
happen may be that the loading of the charge on this structure increases slowly 
and progressively in the gait, while the SDFT receives the load basically all at 
once (Smith and Goodship, 2004). 
In the metacarpal region, proximally to the tendon sheath, DDFT tendonitis are 
found in association with ICL desmitis, while in the carpal sheath area they are 
often secondary to the presence of an osteo-chondroma (Dyson, 2003). 
Unlike the SDFT, the DDFT is more often damaged within the digital sheath. It 
is not yet known whether if these lesions are preceded by degeneration. The 
pathology seldom develops bilaterally (Smith and Goodship, 2004). 
DDFT tendonitis can be claimed as cause of digital sheath swelling in the 
fetlock, even though the causes can be numerous. On the other hand without a 
swelling of the sheath it is hard to identify DDFT‘s lesions (Dyson, 2003). 
The types of DDFT tendonitis are two: the first one is proper of and within the 
tendinous substance (even though it may extend to the edges of the tendon) and 
is quite similar to the classic forms of tendonitis; the second type originates from 
the borders of the tendon, medially or laterally, and usually in the metacarpus-
phalangeal joint area, involving or not the inner part of the tendon. These tendon 
tears are thought to originate from suddenly hitting pressures on the tendon 
when the fetlock joint is hyperextended (Smith and Goodship, 2004). 
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ICL AND SL DESMITIS 
 
 
 
ICL desmitis may occur alone or in association with SDFT tendonitis. Thus the 
pathogenesis is related more to the SDFT than to the DDFT where the ICL 
attaches with its distal insertion. These desmites are frequent in ponies, which 
are instead less like to develop tendinopathies caused by straining (Smith and 
Goodship, 2004). 
 
The SL is divided in three areas that may be injured: the proximal part, the mid 
body and the branches (Dyson and Genovese, 2003). 
The SL proximal desmitis often occurs in forelimb of sport horses and can be 
unilateral or bilateral. In hind limbs this desmitis is of great importance for 
dressage horses competing at high level. Horses with straight or hyperextended 
fetlock and pastern seem to be more likely to develop this pathology (Dyson and 
Genovese, 2003). 
The mid-body SL desmitis is most commonly found in forelimbs than in hind 
limbs. It is quite frequent both in Standardbreds and Thoroughbreds (Dyson and 
Genovese, 2003). Trotting horses seem to tolerate better serious damages to the 
SL compared to Thoroughbreds (Dyson et al., 1995). 
The desmitis of SL branches (medial and lateral) often occur in any type of sport 
horse, both in fore and in hind limbs. The lesion usually involves only one 
branch in one single limb, even though in hind limbs both branches may be 
affected (Dyson and Genovese, 2003). 
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SYMPTOMS AND DIAGNOSIS OF TENDONS AND 
LIGAMENTS INJURIES 
 
 
 
The diagnosis of a tendon lesion is usually based on the anamnesis (usually 
lesions are related to traumas occurred during strenuous training) and on the 
relieving of signs of inflammation with the clinical examination (swelling, heat, 
pain, lameness). Thus the clinical symptoms of tendinitis vary depending on the 
poignancy of the inflammatory response and the degree of mechanical 
compression. 
The cases of mild acute tendinitis present little increase of the volume of the 
tendon, secondary to the inflammatory edema. By palpation limited heat and 
pain are relieved. For the most subtle cases the palpation must be very accurate 
both in charge and with lifted limb. 
when the tendinitis is more severe the inflammatory response is intense and 
swelling, heat, pain and lameness become much more evident. Increased pain 
can be shown either by bad laming or with high sensibility at touch on the 
interested area. In the worst cases the alteration of the tendon substance can be 
palpated (Smith and Goodship, 2004). 
Lameness is not always evident and is related to the degree of inflammation 
rather than to the severity of the lesion. In the majority of cases lameness is 
severe at first when tendinitis is developed. The position of the limb while 
standing can be modified depending on the structural damage and the gravity of 
the injury. When there is a bad SDFT tendinitis the angle of the fetlock joint at 
rest can be normal thanks to the other means of sustenance of the joint (SL and 
DDFT). When the charge on the limb increases (i.e. when the contralateral limb 
is lifted) the injured limb shows a hyperextension of the fetlock (Smith and 
Goodship, 2004). 
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The chronic stage of a tendonitis manifests trough fibrosis and a swelling hard 
and stiff appears on the palmar/plantar aspect of the distal part of the limb. 
When the bulk is remarkable the posterior aspect of the metacarpus/metatarsus 
assumes a typical humpy appearance. When the lesion happens to be right under 
the fetlock the hump appears spheroidal. During chronicization there may still 
be hotbeds of acute inflammation within the lesion testifying the healing process 
is in progress or, sometimes, that a new trauma is interjecting. 
In normal tendons the edges are clearly identified by palpation while in course 
of a chronic process it is not as easy because of the fibrosis and the thickening. 
The horse may seem normal at walk and at trot and present lameness at faster 
gaits (McIlwraith, 2002). 
 
Diagnosing a SDFT lesion in its acute phase is easy because of the swelling of 
the involved area due to the exudative process. The local heat and pain 
contribute to the identification of the site of lesion. Very often it is recognized 
that an injury has occurred because of the lameness that appears, and that can be 
quite variable in intensity (McIlwraith, 2002). It must be remembered that in 
mild lesions the edema doesn‘t develop right away. 
 
Diagnosing a DDFT injury is quite easy too, yet in this case the palpation must 
be much more accurate as the tendon is covered by the SDFT. Walking the 
horse can help as the lameness will increase with exercise and reduce with stall 
rest. As the inflammatory process goes on it becomes possible to identify a 
localized swelling going from the distal part of the palmar aspect of the carpus 
to the whole metacarpus, and which usually is more evident on the medial side 
and hot and painful at palpation. Ambulation is compromised and steps appear 
short and faltering (McIlwraith, 2002). 
 
The clinical signs of a SL desmitis are quite similar to those of flexor tendons‘. 
In the acute phase heat, edema and swelling can be appreciated by palpation in 
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the injured area, even though they are not always present. Slight differences are 
shown in the characteristics of the lameness depending on the affected portion. 
Proximal desmitis 
Proximal SL desmitis start with sudden lameness that can be transient and 
disappear in only 24 hours in forelimbs; in hind limbs the lameness is 
usually more severe and lasting. Often in trotting horses the lameness can 
only be seen with a high speed gait. Very frequently the single lesion 
passes unnoticed and when the desmites develops in the contralateral limb 
the horse begins to be reluctant to move other than showing a clear 
lameness. 
Acute desmitis may present with localized heat in the proximal region and 
occasionally a slight edematous swelling on the palmar lateral aspect of 
the metacarpus or seldom on the palmar medial side. Pain can be evoked 
by palpation. Sometimes the edges of the ligament may feel rounded at 
touch. In chronic desmitis palpable anomalies are usually absent (Dyson 
et al., 1995). 
Mid-body desmitis 
SL mid-body desmitis compromise horse‘s performances other than 
induce severe lameness. The clinical signs (localized swelling, heat and 
pain) are more evident compared to those seen with proximal desmitis; 
lameness is instead milder, indeed often undetectable. When lameness is 
present it usually improves or disappears after a few days of stall rest. 
The appearance of pain referable to SL desmitis must be carefully 
evaluated and eventually related to recent strenuous work or training: pain 
is usually manifested right after an intense activity with no detectable 
alteration of the ligament. On the contrary the absence of pain cannot 
exclude the desmitis, as chronic pathologies mainly run by without pain 
manifestations. The degree of swelling is quite variable: there may be a 
bulk localized to the ligament or involving all of the surrounding 
structures. 
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In many horses when clinical signs disappear it is still possible to 
recognize the site of lesion by ultrasonography. These horses may still be 
capable to return back to sport activity. There is though a relatively high 
percentage of recurrent SL desmitis despite long periods of stall rest (over 
12 months) which might be due to incomplete healing of the ligament 
(Dyson et al., 1995). 
Desmitis of the branches 
The degree of lameness ranges enormously depending on the extent of the 
lesion but may not be present at all. Exception is made by old dressage 
horses often presenting both medial and lateral branch desmitis and being 
very lame (Dyson and Genovese, 2003). 
A swelling of the involved branch and the surrounding soft tissues can 
usually be palpated along with localized heat. In course of acute desmitis 
pain may be evoked by palpation of the involved branch, its edges and the 
corresponding sesamoid bone. Palpating the branch may be difficult when 
the tendon sheath is swollen too. 
SL branch‘s acute lesions in forelimbs may present in association a 
distension of the metacarpo-phalangeal joint capsule and pain after 
passive forced flexion. Also the injuries of the branches can be detected 
by ultrasound examination also long after the trauma (Dyson et al., 1995). 
  
45 
  
COLLATERAL EXAMS 
 
 
Ultrasound is the most important mean of collateral examination for tendon and 
ligament injuries. Tendonography has been used for years to define thoroughly 
the lesions within the tendon sheaths but has been now completely substituted 
by ultrasonography which is less invasive (Dyson and Denoix, 1995). 
To perform tendonography air is initially injected in the digital flexor tendon 
sheath and afterwards in the surrounding subcutaneous tissue, among tendons, to 
outline the tendons. Afterwards radiographies are performed and compared 
between them. In case of alterations within the tendon sheath though, tenoscopy 
is the first choice technique to be used as goes far beyond the diagnostic 
sharpness of ultrasound. 
 
 
 
Ultrasonography 
 
The use of ultrasonography allows to determine thoroughly the site and the 
extent of the lesion. It plays a fundamental role also in the follow-up of clinical 
cases allowing to plan at the best the rehabilitation protocol for the horse. The 
management of the rehabilitation period should ideally plan ultrasound controls 
every 2-3 months (Smith, 2008). To achieve diagnosis the injured area should be 
evaluated within 4-7 days after injury, as many lesions tend to expand in a few 
days following the primary lesion (Davis and Smith, 2006). 
Dyson and Denoix assessed that good ultrasonographic images can be obtained 
by using either a convex or a linear probe which must be as large as to be able to 
give visualization of the whole section of the DDFT. On the other hand the 
probe should have perfect contact with the limb also for longitudinal scans and 
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for this reason should not be too big (Dyson and Denoix, 1995). The structures 
found in the palmar region of the metacarpus can suitably be evaluated by 
placing the probe on the palmar aspect of the limb. To investigate the SL 
branches medial and lateral scans must be performed in the proper areas. Limbs 
must be completely scanned both in cross and longitudinal section and the 
tendons and the damaged areas should be measured. 
The first structure the probe meets is the skin. The second structure to be 
visualized is the SDFT whose echo structure is quite homogenous. The tendon 
presents a rounded shape in the very proximal metacarpal region and flattens as 
it runs distally. Between the palmar surface of the tendon and the skin there is a 
thin anechoic line which is the synovial fluid within the tendon sheath. 
The DDFT is slightly more echogenic and oval compared to the SDFT: its 
proximal and mid portions are thicker on the lateral than on the medial side, 
while the distal part is generically wider. Medially to the DDFT a consistent 
blood vessel (median artery) can be visualized: it can be differentiated from a 
lesion both for the presence of blood flow and the localization beyond the 
tendon edges. 
The ICL can be observed in the proximal third of the metacarpus; it is separated 
from the DDFT by an anechoic layer, which is the synovial fluid within the 
carpal sheath. In normal conditions the ICL is the most echogenic among these 
structures especially in the distal third, where it becomes thinner and merges 
with the DDFT. Between the ICL and the SL the medial and lateral palmar veins 
of the fetlock can be visualized (Genovese and Rantanen, 1998). 
With ultrasound all of the features of a lesion can be evaluated: the increase of 
volume, the modification of the shape, the alterations of echogenicity, the 
pattern of fibers, and the eventual surrounding inflammatory reaction. 
The loss of the normal echogenicity can be due either to the damage to the 
structure of fibrils or to the inflammatory process (with hemorrhage, edema and 
cellular infiltration of the first stages). In general the increase in the content of 
water in the tissue causes a decrease of echogenicity. 
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At the ultrasound examination a tendon undergoing an acute process presents 
increased volume, decreased echogenicity (either generally or focally, i.e. core 
lesion), reduced longitudinal strand pattern, and modified shape, position, edges. 
There may even be completely anechoic areas. 
Chronic tendinopathies are presented instead with a widely ranging increase of 
volume of the tendon which will appear with uneven echogenicity and pattern. 
While investigating tendinopathies it is quite useful to evaluate dimension, 
shape and appearance of both the injured tendon and the contralateral, as many 
pathologies usually are bilateral (Davis and Smith, 2006). 
The palmar aspect of the metacarpus is divided in six zones, each more or less 4 
cm long (1A, 1B, 2A, 2B, 3A, 3B). Zone 1 includes the beginning of the SL and 
the exit of flexor tendons from the carpal sheath. Zone 2 covers the mid third of 
the metacarpus and includes the structures distal to the SL branching. Zone 3 
corresponds to the distal third of the metacarpus and includes the fetlock. The 
metatarsus is longer and it is thus divided in eight zones (adding zone 4A and 
4B) (Sande et al., 1998). 
The dimension of the lesion must be evaluated both in longitudinal and 
transverse scans. Placing the probe in longitudinal section the proximal-distal 
extension of the lesion and the degree of misalignment of fibers are evaluated. 
The transverse scan instead allows to measure the percentage of damaged cross 
sectional area (CSA) as a ratio on the whole diameter of the tendon. This scan 
allows to understand whether if the lesion is completely within the tendon 
matrix (central lesion) or it extends to the margins of the tendon (marginal 
lesion) (Rantanen et al., 2003). 
 
To characterize tendons and ligaments injuries all of the following parameters 
must be evaluated (Craychee, 1995): 
 Region or site of lesion 
 Length of lesion 
 Modification of the echogenicity 
48 
  
 Pattern of the modified echogenicity (i.e. homogenous or not, focal or 
diffused) 
 Longitudinal alteration of fibers 
 CSA of lesion 
 Changes of the aspect of the lesion over time 
 
The classification of the lesion can also be made by type scoring (Rantanen et 
al., 2003) based on the echogenicity pattern: 
 Score 0: isoechoic 
 Score 1: slightly hypoechogenic 
 Score 2: mixed echogenicity (50% isoechoic and 50% anaechogenic) 
 Score 3: totally (or almost) anaechogenic 
 
The evaluation of the cross-sectional area (CSA) of the lesion gives an important 
parameter for the quantification of the damage and the severity of the injury. It 
must be measured in the point of maximum extent of the damaged area, in 
transverse scanning, and related to the total sectional area of the tendon/ligament 
(Smith, AAEP 2008): 
 < 10%  mild lesion 
 10% - 40%  moderate lesion 
 >40%  severe lesion 
 
There also is a scoring system for fiber alignment in longitudinal scanning 
which refers to the amount of fibrils with destroyed crimp pattern (Genovese 
and Rantanen, 1998): 
 Score 0: >75% of fibers are parallel 
 Score 1: 50% - 75% of fibers are parallel 
 Score 2: 25% - 50% of fibers are parallel 
 Score 3: <25% of fibers are parallel  
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Chapter 3 
 
Tendons‘ and ligaments‘ healing process 
 
 
 
THE HEALING PROCESS 
 
 
 
Tendons and ligaments are different in many ways, as for morphologic, 
biochemical, and tensile features. Even within the same joint, ligaments have 
their own peculiar features which include the healing response. 
Studies about tendon and ligament healing processes have highlighted how low 
the intrinsic capability to heal of some ligaments can be, and how they would 
not recover after a rupture, while others would be fixed even without a complete 
restoration of morphologic and biomechanical properties of the original tissue 
(Woo et al., 2000). 
As for any other tissue, after an injury the tendon starts to heal with an 
inflammatory reaction. The severity and the extension of the lesion determine 
the proportion for the production of fibrin and of inflammatory cells (Davis and 
Smith, 2006). 
In the whole process both intrinsic and extrinsic factors are involved. The 
extrinsic component is the main and most important, and it is represented by 
fibroblasts and capillaries produces by the peritendinous tissue. The intrinsic 
component is supported by the endotenon whose cells act as active fibroblasts. 
50 
  
This recent discovery has overcome the previous belief for which the tendon 
was considered an inert structure, almost without vessels and reparative 
properties (McIlwraith, 2002). 
The pathologic process developing a tendinitis is divided in four phases; the 
initial, subclinical phase though is hard to be identified both by simple palpation 
and by an ultrasound examination. Thus the pathological conditions clinically 
detectable reduce to three phases: inflammatory acute phase, reparative sub-
acute phase, and remodeling chronic phase. 
Acute phase: it starts when a clinically evident problem onsets and lasts for 
about 1-2 weeks. Its duration is nevertheless quite variable depending on the 
type of lesion and the promptness of the therapeutic intervention. This phase is 
characterized by intra-tendinous hemorrhage, increased blood supply, 
development of edema and leucocytes infiltration (firstly neutrophils, then 
macrophages and monocytes) (Smith, 2003). 
Sub-acute phase: it starts a few days after the lesion onset, it overlaps with the 
acute phase and culminates after 3 weeks. It is characterized by a marked 
angiogenic activity and storing of fibroblasts within the injured tissue. 
Fibroblasts derive by the resident tenocytes, by the cells of the endotenon and 
the peritendon and by blood monocytes. To repair a tendon (it is a properly 
called reparation and not regeneration) fibroblasts produce scar tissue mainly 
composed by type III collagen fasces randomly disposed. Type III collagen 
represents the 10% of total collagen in a normal tendon and increases up to the 
50% in this process. GAG levels increase and COMP levels decrease. The scar 
initially produced is much weaker than the normal tendon and this makes the 
tendon more likely to incur in a relapse of the pathology in the same area. 
Relapses drag on over time these phases and the lesion worsens (Smith, 2003). 
Chronic phase: it begins a few months after the injury. Type III collagen is 
converted in type I and the fibrils rearrange longitudinally along the tension 
lines (Smith, 2003). In association to these histologic changes the tensile 
resistance of the tendon increases of 3 times from the eighth to the twelfth week. 
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After twenty-four weeks the reparation tissue has been transformed in a properly 
called scar. Nevertheless even a small quantity of immature collagen tissue can 
predispose the scarred area to incur in a relapse (Davis and Smith, 2006). 
The scar tissue is usually made of weaker substance compared to the normal 
tendon, but the large amount of scar tissue produced may even make the tendon 
stronger (Smith and Goodship, 2004). The final outcome of the tendon healing is 
a scar of connective tissue and not of tendinous tissue. This scar may restore the 
anatomic integrity of the tendon but not the tensile and elastic properties of the 
normal tissue (Davis and Smith, 2006). 
 
The prevalence of the intrinsic healing mechanism other than the extrinsic 
potentially can lead to less problems due to the formation of peritendinous 
adhesions (McIlwraith, 2002). In the healing process of many tendon injuries 
though, the peritendinous tissues are quite involved, with the result that the 
fibroplasia binds all of the structures exposed in a mass of cartilaginous scar 
tissue. The resulting adhesion between the tendon and the surrounding tissues 
may have the negative effect to limit or bar the skimming of the healed tendon, 
grave consequence that can only be prevented with a cautious and early 
rehabilitation therapy (Davis and Smith, 2006). 
The adhesions that form inside the sheath, and that progressively limit the 
movement of the tendon, although guarantee some supply for blood and cells, 
thus they must be considered as the physiologic response spurring the tendon to 
heal. In fact the portions of tendon within the tendon sheath have poor healing 
responses probably due to the absence of the blood supply of the peritendon 
(Smith, 2003). 
Relapses are quite recurrent also after a complete recovery. They can occur in 
the same tendon, in the contralateral or in other structures supporting the joint. A 
completely recovered tendon (15-18 months after the initial lesion) is often 
stronger than before but less elastic. The result is that in the adjacent regions 
there is a higher concentration of tensile forces. When the relapse involves the 
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same tendon of a previous lesion it occurs in the same point or in the 
immediately adjacent portions. Contralateral tendon lesions are considered 
properly called relapses because bilateral are the degenerative processes and the 
clinical tendonitis as previously described (Smith, 2003). 
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THE PROGRESSING OF LESIONS: ACUTE VS 
CHRONIC, TWO DIFFERENT ENVIRONMENTS 
 
 
 
Once a lesion is produced in any biological structure an inflammatory response 
is established: the progression of the acute inflammation must be considered as 
the first phase of the healing process. 
The healing process of a lesion is a biological mechanism characterized by 
countless molecular interactions nowadays only partially understood.  A fault in 
the harmonic succeeding of these interactions leads to the chronicization of the 
wound. From decades it has been demonstrated how important are the 
differences between the microenvironments of acute and chronic lesions from a 
biochemical point of view. 
In chronic wounds the exudate obstacles the cell proliferation which is instead 
one of the basis of the success of the healing process and is stimulated by the 
acute wound exudate. 
In vitro studies on endothelial cells and fibroblasts have showed that 
interleukine-1 and the tumor necrosis factor-α, respectively produced by 
neutrophils and lymphocytes, directly stimulate the synthesis of metallo-
proteinasic matrix (MMPs) and inhibit the synthesis of the tissue inhibitors of 
metalloproteinases (TIMPs). From this it is easy to understand that after 
prolonged exposition to these pro-inflammatory cytokines the level of MMPs 
greatly increase compared to the TIMPs (Trengrove et al., 1999). 
The MMPs comprise a number of zinc-dependent enzymes (collagenase, 
gelatinase, and stromelysin) responsible for the degradation of the extracellular 
matrix like fibronectin, collagen, laminin, proteoglycans, and elastin. These 
enzymes have an homologous structure and are secreted in their proenzyme 
form (Wysocki et al., 1993). 
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Both in vitro and in vivo studies have demonstrated the importance of proteases‘ 
role in the physiologic healing process, and how the levels and the time of 
expression of these enzymes must be limited and strictly controlled either by the 
activation of plasmin or by the presence of the TIMPs. An overproduction of 
MMPs fosters an excessive disruption of the matrix undermining the healing of 
the tissue. Studies about chronic wounds in humans have shown that a wound 
environment where proteases are widely expressed leads to the development of 
pathologic healing and chronicization. This finding is supported by the high 
concentration of MMPs retrieved in the exudate of such chronic lesions 
(Wysocki et al., 1993; Trengove et al., 1999). 
It is possible that the imbalance between MMPs and TIMPs  in a wound during 
the healing interjects not only with the disruption of the extracellular matrix but 
also with the degradation of growth factors and their respective receptors 
(Trengrove et al., 1999). 
In chronic processes growth factors are out of balance and their title decreases 
progressively. There are three possible explanations for this to happen; growth 
factors are in fact thought to be either entrapped in tissues, or bond by 
macromolecules, or hampered in their action by the presence of fibrin. Another 
mechanism inducing the decrease of growth factors is the increase of proteases. 
It is also true that, besides the imbalance between anabolic and catabolic factors, 
the capability of cells to properly feedback to growth factors is generally 
lacking. In chronic wounds there are large amounts of old cells that have poor or 
no capacity to respond to anabolic signals; these aged cells may also be in a 
resting phase of their cellular cycle, thus only temporarily inactive. The deficit 
of cell responses is confirmed by the decrease of fibroblast proliferation 
stimulated by TGF-β1 in human patients with venous ulcers. In the same studies 
a reduced expression of receptors and a number of dysfunctions in the 
transduction of biochemical signals have been recorded (Whitney, 2005). 
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THERAPY 
 
 
 
Tendons and ligaments lesions are very common in sport horses and have a 
dramatic impact on the economy of the racing field. 
The incidence of this sort of injuries is nowadays still high, even if in the last 
years the knowledge about the clinical aspects of the problem has greatly 
increased and the diagnostic and therapeutic means much improved. 
Traditional therapeutic treatments include both a medical and a surgical 
approach aimed to reduce inflammation and prevent further damages (Dahlgren, 
2009). The various therapeutic options can be classified in pharmacological, 
physical and surgical. 
 
Cold: the application of ice or cold water (hydrotherapy) has been the 
cornerstone of treatment for acute tendonitis and desmitis and is even nowadays 
still considered of valuable help. It is aimed to the reduction of inflammation, 
thus of the exudate and the chemotactic agents responsible, over time, for 
damaging the tendon matrix originally healthy (Dowling et al., 2000). Cold 
should be applied several times per day, for 20-30 minutes each time, until the 
acute phase of inflammation passes. Prolonged application should be avoided as 
it may cause a feedback vasodilatation (Henninger, 1994). Nowadays there are 
new commercial products that give the possibility to apply pressure cyclically 
along with cold water. Cyclic compressions stimulates lymphatic drainage and 
transmits the cold also to deeper layers (Dahlgren, 2009). 
 
Bandage: in the acute phase of the lesion controlling the swelling and 
supporting the injured limb is essential. Bandages increase the pressure of the 
interstitial fluid contrasting Starling‘s forces that would otherwise induce licking 
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of fluid out of blood vessels (Henninger, 1994). A simple soft bandage is usually 
recommended even with habitual leg wraps. The bandage can be changed every 
day or even more often in case of repeated application of ice/cold water 
(Dahlgren, 2009). 
 
Stable confinement: a period of stable rest is fundamental for the healing of 
tendinitis and desmitis. The length of the period ranges widely from a minimum 
of two months up to one year. For SL desmitis the minimum period of rest 
should be 4-6 months (Arthur, 1995). 
 
Physiotherapy: physiotherapy, intended as a series of controlled exercises, 
could be started during the healing process, after the acute inflammatory phase. 
A good rehabilitation protocol should be applied regardless of the type of 
therapy chosen to treat the lesion. Rehabilitation schedules usually foresee 
progressively increasing physical activity and workload, from walk to gallop, 
and last often more than 12 months. An ultrasound control should be performed 
every 3 months to adjust the rehabilitative program to the case. The duration of 
the rehabilitation is quite important: a number of studies show how the 
possibility to get back to the activity without incurring in a relapse is very low 
for resting and rehabilitative period shorter than 6 months (Dowling et al., 
2000). 
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PHARMACOLOGIC THERAPY 
 
 
 
In the past the only therapeutic forms in use were represented by thermo-genic 
treatments, in the form of creams or lotions. These treatments stimulate blood 
circulation and the production of abundant leukocytosis through which the 
decomposition of the products of inflammation was achieved. Their efficacy 
was to be retained valuable only in presence of an hyper-acute case of tendinitis; 
they would in fact not have any therapeutic effect in those cases where necrosis 
was already present. In later days the use of corticosteroids has taken over and 
more recently have the non-steroidal anti-inflammatory drugs, that unlike 
steroids have met unanimous favor. 
 
Anti-inflammatory drugs: the use of short-action corticosteroids in the hyper-
acute phase of the lesion (less than 24 hours after injury) seems to reduce the 
inflammatory reaction but there is no evidence of better final outcome with their 
use. The use of corticosteroids in the sub-acute/chronic phase instead inhibits the 
fibroblastic feedback which is essential for the tendon healing. The intra-lesion 
use of corticosteroids causes damages such as necrosis of collagen and 
hyalinization. 
Dymethilsulfoxide (DMSO) has been widely used for its anti-inflammatory 
activity. It has good capacity to enter cells‘ membranes and inactivate free 
radicals which are quite harmful for the undamaged surrounding tissue. DMSO 
is commonly believed to have scarce toxicity, yet studies on rats have 
demonstrated how the local application of DMSO can weaken the tendons of the 
tail of such animals (Henninger, 1994). 
The use of non-steroidal anti-inflammatory drugs (NSAIDs), like 
phenilbutazone and flunixine meglumine, has given controversial results in the 
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treatment of inflammation. They are useful to reduce inflammation, swelling and 
pain when used in the first two weeks after injury, even if they should be 
considered effective only for their analgesic power. In fact it is quite 
problematic to demonstrate in horses a significant action in vivo. The prolonged 
used of these drugs causes collateral effects such renal damages, gastric ulcers 
and colic syndrome (Henninger, 1994; Dahlgren, 2009). 
Sodium hyaluronate: hyaluronic acid is a natural substance present in high 
concentration in synovial fluid of joints and tendon sheaths. It also has a 
structural role in connective tissues. Its use for intra-lesional or peritendinous 
injection as therapy for acute tendonitis presents conflicting results. 
Preliminary studies on lab animals show that the high viscosity and molecular 
weight of the sodium hyaluronate gel, injected between the tendon and its sheath 
(peritendinous use) may favor scarring of the tendon and limit the adhesions. 
Gaughan promoted a study on horses and the tendon that were such treated did 
not develop significant adhesions with surrounding tissues. Good results were 
obtained in regards of speed and quality of the healing (Gaughan, 1994). 
Spurlock and colleagues also obtained good result treating 63 horses with SDFT 
tendonitis with Hilartil V: 60% of the treated horses showed echographic 
healing of the lesion in a lapse of time of 6 months at the most (Spurlock et al., 
1999). 
Intra-lesional injection of sodium hyaluronate doesn‘t seem to reduce the 
incidence of relapses on the basis of the clinical outcome, when comparing cases 
of treated and untreated horses (Dahlgren, 2009). Hyaluronic acid‘s use isn‘t 
common because of its high cost and the difficulties of acquisition. 
Polysulphated glycosaminoglycans (PSGAGs): glycosaminoglycans (GAGs) 
are an important component of cartilage. PSGAGs simply are GAG added with 
sulfates. The drug acts by inhibiting cartilage-destruction-linked enzymes and by 
reducing inflammation. PSGAGs have been used to treat joint degenerative 
diseases for several years. In the treatment of tendonitis they are used in the 
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initial inflammatory phase and reduce swelling and pain (Dahlgren, 2009). A 
study on 8 horses with a collagenase-induced SDFT lesion highlighted how the 
treatment with PSGAGs speeded up the tendon healing compared to control 
horses. The results were evaluated both with ultrasound and histopathology 
(Redding et al., 1992). 
Another study on a small number of horses with SDFT lesions and treated with 
PSGAGs showed how this therapy allowed horses to get back to sport activity 
much more than other conservative therapies or laser therapy. Data revealed 
though that less than 50% of the horses were able to compete again and the 
incidence of relapses was very high (Henninger, 1994). In 1996 PSGAGs were 
applied on 150 horses with SDFT acute tendonitis. On the basis of a clinical 
evaluation in 80% of the cases the treatments led to a favorable outcome. The 
medium rate of return to activity was 72% with a 72% of it with total recovery 
(Dow et al., 1996). 
Beta-aminopropionitrile Fumarate (BAPN-F; Bapten): the molecule acts 
binding irreversibly the lysil oxidase, an enzyme that is responsible for the 
formation of cross-links among collagen fibers during the initial reparation of 
the tendon. Crosslinks are soluble and easily denaturized with heat. When 
collagen maturates bonds stabilize to impart the characteristic biomechanical 
features to the fixed tissue. The BAPN decreases the formation of scar tissue 
encouraging the alignment of fibers (Henninger, 1994) and reduces the 
incidence of relapses but does not accelerate the healing process. The ideal 
moment to perform the intra-lesional injection of BAPN is between 30 and 60 
days after injury, which is the lapse of time when the majority of crosslinks are 
built (Dahlgren, 2009). In 1998 Virginia Reef reported a study on Bapten‘s 
application to tendon lesions in horses. The 70% of treated horses returned to 
races despite the severity of the injury. The ultrasonographic appearance of the 
lesions showed substantial improvements too. In later days the enthusiasm about 
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this treatment faded because of some cases of spontaneous lacerations of treated 
tendons. 
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PHYSICAL THERAPY 
 
 
Physical therapy includes low intensity ultrasound, laser therapy with low 
frequency infrared rays and electromagnetic therapy (Watkins et al., 1985). In 
many cases the results obtained with these therapies aren‘t any better than those 
obtained with other preservative therapies (Dowling et al., 2000). 
Laser therapy: the biological effect of laser depends on the characteristics of 
the laser light (frequency, wave length and energy), of the type of treated tissue, 
and on the duration and the frequency of the application. Laser therapy is 
especially useful for the treatment of superficial wounds where the healing 
process is consistently sped up (Henninger, 1994). In Kaneps‘s study about 
horse tendons laser therapy‘s application results weren‘t any better than normal 
scarring of the lesion. The failure of the treatment is probably to be ascribed to 
the use of a power lower than the needed to influence the scarring of a wound 
(Kaneps et al., 1984). More recent studies have ascribed to laser therapy the 
capability to stimulate collagen production in fibroblasts, to facilitate the 
remodeling of the newly formed tissue, but not to give back the tendon 
completely its mechanical properties (Kostoulas et al., 1997). 
Ultrasound: the biological effect produced by ultrasound depends on the 
frequency, the intensity and the type of wave produced. Ultrasounds generate 
heat in the tissue they hit modifying the blood flow, the metabolism of proteins, 
the extensibility of collagen, and the permeability of membranes (Henninger, 
1994). Studies in humans have reported consistent therapeutic effects among 
which the increase in the production of collagen, the decrease in scar tissue, and 
the general improvement in the quality of the healing of lesions. In one study on 
rabbit tendons severed and treated with low density ultrasounds and increase of 
the tensile strength of tendons was reported after only ten days. Therapies with 
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high density ultrasound, on the other hand, seem to slow down the healing 
process causing blood stasis damaging the endothelium and decreasing the 
synthesis of collagen (Henninger, 1994). The application of ultrasounds on 
surgically damaged equine tendons revealed quite positive outcome at histology. 
After only 4 weeks from treatment no degenerated areas or signs of 
inflammatory reaction was visible. After 6 weeks the tendon seemed completely 
healed showing only a small scar (Morcos and Aswad, 1978). 
Ionizing radiation: in 1979 Franks performed a study in which 25 of 48 horses 
with teno-desmic lesions got back to sport activity after a therapy with 
irradiation. The worst problems related to this kind of therapy regard the dosage 
of radioactive isotopes for which a proper equipment is strictly required (Franks, 
1979). 
Magnetic fields and electricity: the electric stimulation induces changes in the 
cellular environment, affecting the function and the differentiation of cells. Pain 
decreases, blood flow increases, the edema reduces and the migration of cells is 
stimulated. The biological effects vary on the basis of the properties of the 
electric power used, the schedule of the treatment and the kind of treated tissue. 
Experimental studies have demonstrated how various kinds of cells are able to 
respond to the electric stimulation. Many are the studies on equine soft tissues. 
The direct stimulation with low-power electricity does not bring any 
improvement to the histologic appearance of surgically created skin wounds. 
Watkins et al. demonstrated how a daily electro-magnetic therapy would 
increase vascularization of surgically created lesion in SDFT yet the maturation 
of the reparation tissue and the transformation of collagen were delayed. The 
observations were performed after 8 and 12 weeks from the creation of the 
lesion (Henninger, 1994). 
Extracorporeal shock wave therapy: the mechanism of action of shock waves 
is unknown. Through experimental studies consistent effects have been relieved 
in the treatment of SL desmitis. The most frequent use of shock waves is 
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reported in the treatment of proximal SL desmitis where the average prognosis is 
much more favorable compared to those obtained with other conventional 
therapies. The 41% of horses affected by proximal SL desmitis in hind limbs 
returns to full activity within 6 months compared to the 13% of the horses 
treated with other conventional therapies. This treatment though cannot be 
considered appropriate in case of acute tendonitis (Smith, 2008). 
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SURGICAL THERAPY 
 
 
Tendon surgery is used to treat either chronic tendonitis or the cases of serious 
lacerations and complete severing of the tendon. 
Tenorraphy: a tendon suture is mandatory in case of wide lacerations or sharp 
cuts of the tendon. Some consider this procedure ineffective as the suture would 
offer little resistance to traction. Tenorraphy though is quite useful especially 
when the severed tendon is within the tendon sheath, as the two parts would tend 
to retract, creating a distance hardly fillable by granulation tissue. The utility of 
Tenorraphy is doubted when the loss of tendon substance is massive. 
Splitting: this technique has been used since 1931 to treat chronic tendonitis. It 
consists in the longitudinal cutting of the tendon to create lesions in the fibrotic 
mass of the scar. These lesions are performed a couple of centimeters apart from 
one another on one or more than one parallel planes. The procedure was 
believed to lead to an improvement of the vascularization but recent studies have 
shown how it increases instead the trauma and the production of granulation 
tissue; furthermore there is no alteration on the production of collagen and the 
lameness persists. The surgical splitting of SL hasn‘t produced any favorable 
results in Warmbloods while in Standardbreds there seems to be an 
improvement (Arthur, 1995). 
Splitting has recently been proposed to treat acute lesions other than chronic 
ones: the splitting would in fact allow the drainage of hematomas and intra-
tendinous edema, reducing the dimension of the lesion and improving the 
alignment of collagen fibrils (Dowling et al., 2000). A clinical study 
demonstrated how the splitting of tendons affected by acute inflammation with a 
core lesion would produce a significant reduction of the dimension of the lesion, 
65 
  
of the diameter of the tendon and thus of the grading of the lesion within the first 
8-10 days after surgery. Later on a lower deposition of fibrous tissue was 
registered too. The 81% of horse got back to training and the 68% to activity, at 
the same level where they competed before surgery. These result were quite 
significant considering that the lesions were all graded of 3
rd
 or 4
th
 degree and 
involved an average of the 80% of the CSA of the tendon (Henninger, 1994). 
Synthetic implants: the use of implants of fibers of carbonyls in tendons and 
ligaments was initially experimented by Jenkins (1976) in animals other than 
horses. The first results encouraged the use of carbonyl fibers to treat tendonitis 
and flexors‘ lacerations. Edwards (1978), Valdez (1979), and Langlois (1980) 
were the first ones to consider carbonyl fibers application in equine tendons; 
many other authors followed. In Italy the first one to use carbonyl fibers was De 
Gresti who treated 15 horses with chronic tendonitis (De Gresti, 1990). It was 
then shown that such treatment induces persistent anomalies in the newly 
formed collagen and the outcome intended as the return to competition was 
similar to those obtained with other sorts of treatments. Carbonyl fibers are 
inextensible thus resisting forces apply on the surface of the implant; these are 
probably responsible for the continuous tendon pain relieved in many horses 
undergoing the treatment. The implants cannot be indicated in case of stretch-
induced tendonitis, where the peritendon is usually intact providing itself to the 
healing (Dowling et al., 2000). 
Cauterization: it consists in the application of heat on the lesion by using 
caustic substances (phenols and red mercury) or other burning instruments 
(thermo-cautery). This treatment is used on chronic muscle-skeletal lesions in 
horses with the aim to increase vascularization and exudation of inflammatory 
cells. It has been shown though how this treatment doesn‘t have any positive 
effect on tendon healing, on the type I collagen content and the athletic 
performances; healing is often slowed down and the incidence of peritendon 
adhesions increases. Heat treatment leads to the formation of a scar and the 
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treatment is very painful for the horse. There still are many fans of such therapy, 
either used alone or in association with other treatments, yet the obtained result 
are not straightforward positive (Dowling et al., 2000). 
Other surgical solutions 
SCL desmotomy: this technique was proposed in 1986 to treat SDFT 
tendonitis. By severing the SDFT accessory ligament the peak of charge applied 
on the SDFT is reduced and the charge on the muscle increased. The results 
obtained after the desmotomy are wide-ranging. A percentage varying between 
the 52% and the 82% of the treated horses gets back to competition at the same 
or higher level than before (Dowling et al., 2000). In a study on 62 
Thoroughbred horses 92% of patients returned to training and 66% ran 5 times 
after surgery at the most. Forty-seven % of the horses returned to competition 
maintained or increased the gaining per start and 86% got back to its own 
competition level. Only 19% of the horses had a recurrence of the pathology. 
The results were quite encouraging compared to those obtained using 
conservative treatments (Henninger, 1994). Through a retrospective study it has 
been otherwise shown that the exercise following the desmotomy causes a 
worsening of the ultra-sonographic appearance of the acute tendonitis (Dowling 
et al., 2000). 
PAL desmotomy: this technique was proposed to treat lesions of SDFT 
and DDFT in the fetlock area. The procedure is indicated when the annular 
ligament forbids a normal skimming of flexor tendons. The surgery is performed 
in general anesthesia, better if with tenoscopy than with an open surgery (Davis 
and Smith, 2006). 
Fasciotomy: this a surgical technique used to treat proximal SL desmitis 
in hind limbs that do not improve with conservative therapy. A fasciotomy of 
the fascia wrapping the SL is performed to reduce the compression in the 
proximal tract of this ligament (Davis and Smith, 2006).  
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REGENERATIVE MEDICINE 
 
 
The aim of regenerative medicine is to restore the original architecture and 
biomechanical function to damaged tissues. 
After a tendon lesion the scar tissue that forms induces a decrease on the 
performances and the lesion is likely to relapse. It is thus necessary to substitute 
the damaged tissue with a matrix more similar to the tendon and less to scar 
tissue. Knowing the molecular and mechanic processes involved in the 
development of a tendon or ligament lesion and the pathologic conditions of the 
lesion itself (acute/chronic) allows to a better choice in the most appropriate 
therapy to use (Fortier and Smith, 2008). 
There are 3 fundamental instruments to obtain a good regeneration of the 
damaged tendon (Dahlgren, 2009): 
1. An implant compatible with the attachment and the migration of cells 
able to lead the reconstruction of the damaged area in a three-
dimensional fashion; 
2. A source of cellular precursors able to recruit endogenous stem cells 
possibly differentiating in tenocites; 
3. A physiologic combination of growth factors and cytokines to make 
the tendon matrix reorganize on the given implant. 
 
Implant: there are implants obtained from porcine urinary bladder (UBM). 
Through mechanical and chemical procedures the basal membrane and the 
lamina propria of the bladder wall are isolated and then processed to powder. 
The obtained powder is reconstituted with saline solution and injected in the 
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lesion of the tendon/ligament. In the United States this treatment has been 
applied to hundreds of horses both with tendonitis and desmitis of SL. About the 
85% of the horses returned to the previous athletic level (Fortier and Smith, 
2008). 
 
Stem cells: they are undifferentiated cells able to undergo differentiation in a 
specific cellular line and renovate. Mesenchymal stem cells (MSCs) are adult 
stem cells that can be isolated from bone marrow, muscle, tendon, adipose 
tissue, and can differentiate in cells such as osteoblasts, myocytes, chondrocytes, 
adipocytes, and tenocytes, depending on the tissue they have been implanted in. 
Adult stem cells can thus conduct a regenerative response; furthermore they 
contribute to healing producing bioactive proteins (growth factors and 
cytokines) sending local signals through the recruitment of endogenous stem 
cells; also they induce anabolic effects in the recruited cells and in those already 
present in the tissue (Dahlgren, 2009). 
MSCs are used in tissue engineering, in genic therapy or they are directly 
injected into the lesion. Among these possibilities only the direct injection is 
applicable in clinical practice. Nowadays stem cells are applied in the form of a 
suspension inside the lesions of tendons, ligaments and joints (Dahlgren, 2009). 
Bone marrow aspirate derived stem cells (BM-MSCs). The use of these 
cells has been experimented in laboratories on animals previously submitted to 
surgery to create a lesion. These studies have reported positive effects on the 
organization of the tissue, on the composition and the mechanic properties of 
treated tendons and ligaments. 
The treatment can either consist in the injection of the entire marrow aspirate, of 
a concentrate of stem cells obtained with centrifugation or of a population of 
stem cells cultured in vitro (Fortier and Smith, 2008). 
The injection of MSCs derived from bone marrow in teno-desmic lesions offers 
two great advantages: 1) MSCs can differentiate in mature fibroblasts able to 
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produce new matrix; 2) bone marrow is rich in blood thus it is a powerful source 
of growth factors that favor the healing of the tissue. 
The intra-lesional injection of the whole aspirate is a simple technique, 
immediate (the application can follow right after the diagnosis) and relatively 
cheap. A negative effect, which is quite rare though, is the possibility to have a 
mineralization of the product after the injection (Fortier and Smith, 2008). 
MSCs are nevertheless scarcely concentrated in bone marrow: to obtain a more 
effective concentration in the site of lesion with a marrow aspirate a large 
quantity of product should be injected, eventually provoking negative 
compressions on the healing process (Dahlgren, 2009). 
The use of a centrifuge allows to concentrate the stem cells collected by 
aspiration. This technique offers all of the advantages of both the PRP (Platelet 
Rich Plasma) and of the bone marrow aspirate. The product is autologous and 
can be prepared right after the diagnosis. It also contains all of the three 
component important for regeneration previously described: the implant, the 
growth factors and the stem cells (Fortier and Smith, 2008). 
Also the implant of MSCs cultured in a laboratory and re-suspended in a mean 
allows to overcome the problem of cells concentration, thus giving an effective 
number of stem cells in a small volume. The positive effects of this treatment 
must still be investigated much more thoroughly, yet no negative effects have 
been relieved. Ad advantage is for sure due to the better purity and availability 
of stem cells. The greatest disadvantage of this technique is due to the time 
necessary to cultivate the cells (2-4 weeks), thus the injection cannot happen in 
the acute phase of the lesion (Dahlgren, 2009). The lapse of time between the 
diagnosis and the treatment is fundamental for the positive outcome of the 
therapy. It has been demonstrated that the fibrosis of the sub-acute and chronic 
phases can obstacle the action of the injected product (Fortier and Smith, 2008). 
To be able to intervene in the acute phase a ready-to-the-use product should be 
available before the lesion is created, and this solution is far away to be 
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applicable as the product is autologous. The other disadvantage is the high cost 
of the therapy (Dahlgren, 2009). 
Adipose tissue derived stem cells. The use of adipose tissue as source of 
adult stem cells offers numerous advantages compared to bone marrow: 1) the 
collection technique is easier and less invasive; 2) stem cells are more 
concentrated and the amplification in vitro is not necessary; 3) these stem cells 
show a higher proliferative rate in vitro. 
The population of stem cells isolated from adipose tissue is heterogeneous and a 
physiologic combination of fibroblasts, endothelial precursors, pericytes, 
macrophages, B and T lymphocytes, pre-adipocytes and smooth muscle cells 
(Dahlgren, 2009). 
At the moment the proves of the biosecurity of stem cells are only on the short-
run; so far none of the treated cases has shown any collateral effect, such as the 
development of a tumor, in a time over 5 years from the treatment (Fortier and 
Smith, 2008). 
 
Growth Factors. The therapies implying the use of growth factors for tissue 
regeneration are based on the principle to release one or more than one of these 
factors in the site of lesion. The product that is more widely used is PRP. The 
characteristics of growth factors and of the platelets concentrates are widely 
described in the following section. 
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SECTION 2 
 
The role of platelets concentrates in tendons’ and 
ligaments’ healing process 
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Chapter 1 
 
Platelets 
 
 
 
Besides the well known hemostatic role, platelets are also able to release factors 
promoting tissue repair, angiogenesis, and inflammation: in a site of lesion 
platelets release a wide range of inflammatory and mitogenic molecules 
involved in all of the phases of the healing process of wounds (Rozman and 
Bolta, 2007). 
 
FORMATION, COMPOSITION, PHYSIOLOGY AND BIOLOGICAL ROLE 
OF PLATELETS 
 
 
Platelets are pieces of cells without nucleus and with secretory activity. They 
derive from megakaryocytes of the bone marrow through a controlled process of 
cellular fragmentation (Rozman and Bolta, 2007). 
Megakaryocytes develop from multipotent progenitors CD 34+, myeloid cells 
belonging to the hemopoietic tissue and blood. Megakaryocytes represent 
approximately 0.1-.05% of nucleated bone marrow cells and are sited under the 
capillary twits of bone marrow. Megakaryocytes produce cytoplasmic 
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projections which represent the pro-platelets and that are in contact with blood. 
These projections are afterwards cut off to release platelets in the blood stream 
(Hartwing and Italiano, 2003). 
The proliferation of megakaryocytes is mandatory to have platelets genesis. 
Thrombopoiesis is regulated by a serum factor, thrombopoietin, responsible for 
increasing not only the production of platelets but also of megakaryocytes. Also 
some interleukins (IL-3, IL-6, IL-11) have thrombopoietic activity (Hartwing 
and Italiano, 2003). 
Mature megakaryocytes continuously produce cytoplasmic expansions that are 
filled with cytoskeleton proteins (α- and β-tubulin, actin, myosin, actin-binding 
proteins – ABP – gelosin, profillin, taline, vinculine, and tropomyosin) with 
specific granules and membrane systems. Despite the knowledge that platelets 
are the derivatives of megakaryocytes cytoplasmic projections, the biological 
process leading to the their production is nowadays not completely clear 
(Hartwing and Italiano, 2003). 
Human platelets have discoid shape and a dimension of 1-4 µm of diameter per 
1µm of thickness. In a healthy adult human their number ranges between 
150,000 and 400,000/mm
3
. Equine platelets are also discoid fragments 5-7µm 
long and 1-3µm large, even though in blood they can be as large as 20µm. 
When firstly released in the blood flow platelets are larger and with a greater 
hemostatic power than the circulating mature particles (Hartwig and Italiano, 
2003). The average life of a platelet is 7-9 days, which is the time lapse a 
platelets spends circulating in blood in an inactive form. Afterwards it is caught 
by hemocateretic organs and phagocytized by the system of mononuclear 
phagocytes (Hartwig and Italiano, 2003). 
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Platelet structure (Hartwig and Italiano, 2003) 
 
 
Platelets’ membrane. The membrane of platelets is composed of three layers: 
the glycocalice, the phospholipid layer and the sub-membranous layer (Tablin, 
2000). The glycocalice is the outer layer and is compounded by polysaccharides, 
lipoproteins and glycoproteins; it has glycoproteic receptors involved in the 
adhesion and the activation of the protein. Glycoproteins constitute platelets‘ 
membranous antigens and are divided in three classes: integrin, leucine rich 
proteins and selectin. The main glycoproteins present on the outer surface are 
the collagen receptor, the fibronectine receptor, the vitronectine receptor, the 
fibrinogen receptor, the laminin receptor and the von Willebrand factor receptor 
(Tablin, 2000). 
The central layer of this structure is made of a double layer of phospholipids 
with anticoagulant properties, identical to that of other cells, with trans-
membranous proteins and peripheral proteins acting like membrane receptors. 
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Phospholipids are arranged in the double layer with the polar parts toward the 
outside. 
Negative polar lipids, amino-phospholipids (phosphatidilserine-PS) and 
phosphatidil hetanolamine (PH) constitute the inner part of the phospholipid 
membrane. Neuter phospholipids (phosphatidilcoline – PC) and sphingosine 
(SP) are present in the outer side of the phospholipid membrane. Other lipids are 
present inside the membrane: phosphatidil inositol and lisolectine (Gentry and 
Nyarko, 2000). 
The inner layer of the membrane, the sub-membranous layer, is actually a part 
of the cytoskeleton binding some proteins of the outer layer. The membrane 
folds out forming a series of cliffs which constitutes the open canalicolar system 
(OCS). This system determines an increase of the surface available for the 
exchanges with the surrounding environment thus a quick way of secretion of 
the granules once the platelet is activated (Tablin, 2000). 
Integrins. Integrins are proteins involved in a large number of cellular 
interaction. Along with platelets they favor aggregation and adhesion. The basic 
structure of integrins is formed by two sub-units, α and β, tied by a covalent 
bond. Integrins are internally connected with platelets cytoplasm with a single 
C-terminal tail and externally with the medium by different sub-units with 
extracellular N-terminal domains. The inner portion of integrins is associated 
with signal proteins (G-proteins and tyrosine kinase) and phosphoinositides. The 
most important sub-units of integrins inside a platelet are β1 and β2. The β1 sub-
unit is associated to three different α units. The β3 subunit is connected to the 
glycoprotein IIb-IIIa and to the receptor for vitronectine. The glycoprotein IIb-
IIIa, also known as P-selectine and fibrinogen receptor, is on the surface of the 
α-granules and interacts with fibrinogen, with the von Willebrand factor, with 
the fibronectin and the vitronectine. The externalization of this glycoprotein is 
related to the activation of the platelet (Carmona, 2006). 
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Leucine-rich glycoproteins and other platelet receptors. Leucine-rich 
glycoproteins, especially the Ib-IX-V GP, contribute to the formation of the 
negative charge on the surface of platelets. These glycoproteins have two 
subunits, IbαGP and IbβGP. The outer domains have receptors for thrombine 
and for the von Willebrand factor. The inner cytoplasmic tail is associated to 
actin through its binding protein (ABP). When the von Willebrand factor binds 
to these glycoproteins the cytoplasmic concentration of calcium increases and 
the phosphoatidil-inositol-3-kinase is activated. These phenomena produce the 
activation of the A2 phospholipases and the synthesis of arachidonic acid and 
A2-tromboxane. Other membrane receptors of platelets include receptors for the 
thrombin, for immunoglobulins and for thrombospondin (Tablin, 2000). 
 
Platelets’ cytoplasm. Platelets‘ cytoplasm is compounded of the same 
cytoplasmic proteins of megakaryocytes. In platelets there are two types of actin 
building up the cytoplasm net: globular and linear actin. The strands of actin act 
as a structural support for the different platelet granules and for mitochondria. 
The platelet response is mediated by a contractile activity thanks to the 
polymerization of actin-myosin. 
Other elements of the cytoskeleton are represented by microtubules and 
intermediate filaments. Microtubules are arranged in a twisted fashion to 
maintain the discoid shape of inactive platelets. After platelets‘ activation 
microtubules reorganize and arrange linearly. The adequate assembly of the 
cytoskeleton is fundamental to the centralization of the granules in the platelets, 
the secretion and the retraction of the coagulum (Carmona, 2006). 
 
Platelets’ granules. The platelets of mammals contain three types of granules: 
lysosomal granules, dense granules (also called δ-granules), and α-granules 
(Hartwig and Italiano, 2003). 
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Lysosomal granules contain acid hydrolases, guanine, phospholipases 
and kinases working as protolithic and hydrolytic enzymes. They can 
degrade intracellular material or they can merge into the OCS‘s 
membrane to release their content in the extracellular space (Tablin, 
2000). 
Dense granules represent the storing site for adenylyl nucleotides, as they 
store ADP and ATP. They also contain calcium, phosphorus, and 
serotonin. The ADP induces platelets‘ migration and, along with 
serotonin, provokes the contraction of damaged arteries. The ATP thwarts 
ADP‘s action. Dense granules are less numerous than α-granules (Tablin, 
2000). Alpha-granules contain adhesion proteins (fibronectin, vitronectin, 
thrombospondin), coagulation factors (fibrinogen, factor-V, factor-IV), 
fibrinolysis factors, mitogen growth factors, cytokines, chemokines, 
angiogenesis regulation factors, anti-proteases, bactericide proteins, and 
glycoproteins of the membrane (Tablin, 2000). 
Alpha granules contain numerous growth factors, seven of which are 
greatly involved in wounds‘ healing process. These factors are the platelet 
derived growth factor (PDGF), the transforming growth factor (TGF-β1, 
TGF-β2), the epidermal growth factor (EGF), the vascular endothelial 
growth factor (VEGF), the insulin-like growth factor (IGF-I) and the 
hepatocyte growth factor (HGF) (Anitua et al., 2004). 
 
In the cytoplasm of platelets there are also free-moving glycogen granules. 
Glycogen is the principal source of energy for the metabolism of inactivated 
platelets (Tablin, 2000). 
There are many adhesive proteins: fibrinogen (FG), fibronectin (FN), vitronectin 
(VN) and thrombospondin-1 (TSP-1). During the hemostatic process part of 
these factors attaches to platelets receptors and participates directly to the 
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creation of the thrombus. Fibrinogen potentiate the effect of interleukin-3 on the 
hemopoietic progenitors in humans, while fibronectin and vitronectin take part 
to the wound healing process. Among fibrinolytic proteins the PAI-1 is the 
natural inhibitor of the activator of tissue plasminogen, main inducer of vascular 
fibrinolysis. The PAI regulates fibrinolysis and can bind vitronectin to improve 
the interaction between matrix and cells. 
Osteonectin is another protein derived by platelets and is also produced by 
osteoblasts. It is capable to create a complex with plasminogen and tie it to the 
collagen. 
 
Platelets’ activation and adhesion. Platelets can be activated by various 
mechanisms: by direct contact and adhesion to the sub-endothelial layer for an 
endothelial lesion, by the action of physiologic agonists (thrombin, ADP, 
collagen, A2 thromboxane, epinephrine, platelets activation factors) interacting 
with specific receptors of the membrane associated to the G-protein, and by 
other mechanisms that produce intracellular signals (Rozman and Bolta, 2007). 
Platelets adhere to the sub-endothelium thanks to the integrins of the membrane 
and to the help of the adhesion proteins of the endothelium (Carinci, 2002). In 
these conditions the coagulation cascade follows and thrombin is formed. 
Thrombin contributes to stimulate platelets‘ activation with a positive feedback 
response (Rozman and Bolta, 2007). After platelets‘ activation has occurred a 
series of events follow: platelets change in shape, secrete the content of granules 
(including ADP, fibrinogen and serotonin), aggregate, and then the coagulum is 
retracted (Rozman and Bolta, 2007). 
 
Platelets’ shape modification. Platelets quickly pass from their discoid shape 
of the inactive phase to an irregular spherical figure, with pseudopods which are 
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firstly very short and then become thinner and longer. This new shape allows the 
contact between platelets. This mechanism takes place thanks to the great 
majority of the molecules of the cytoskeleton: microtubules rearrange and the 
actin strands associated to the membrane contract. The shape rearrangement is 
strictly dependent on ATP. If the stimulus activating the platelet is either week 
or too short, the platelet quickly regains its initial status becoming completely 
morphologically identical to a platelet which has never been stimulated. 
Platelets regaining the inactive status may not respond, in a refractory phase, to 
a second stimulus, even when this second one is stronger and longer than the 
previous. This probably is a mechanism of control tending to self-limit the 
platelet activation process. When the stimulus is effective instead, a series of 
other actions follow to the shape modification, such as the reaction of granules‘ 
content release and aggregation. From the functional point of view the shape 
changing has consequences of great importance as it makes the platelet factor 3 
(PF3) available on the membrane of the platelet. 
The platelet factor 3 is a phospholipid (phosphatidilserin) mainly sited on the 
inner side of plasmatic membrane in an inactive platelet being thus 
unapproachable: the change of shape reorganizes the membrane which exposes 
on the outer side the PF3. The PF3 is involved in some reactions of coagulation 
(Gentry, 2000). 
 
Secretion. The secretion process of platelets is an active ATP-dependent 
procedure following adhesion. The secretion of the content of platelets‘ granules 
occurs through a mechanism of exocytosis and is related to the increase of 
calcium concentration in the platelet (Rozman and Bolta, 2007). 
While the shape changing takes place, granules are carried close to the OCS 
(centralization of granules) and their membrane merges with the canalicolar 
membrane allowing secretion (Tablin, 2000). 
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Aggregation. Platelets aggregation is mediated by fibrinogen molecules or the 
vWF, which connect the platelets binding the glycoproteic IIb/IIIa complexes to 
adjacent platelets creating a platelet aggregate. Each platelet has 50 000-80 000 
IIb/IIIa glycoproteins on its own surface. To be able to bind the fibrinogen 
glycoproteins must be first converted from a status of low affinity to the one of 
high affinity. This happens through a process called inside-out signaling that 
starts right after the activation process (Rozman and Bolta, 2007). In inactive 
platelets the glycoproteic complex IIb/IIa is presented in its inactive form as the 
two glycoproteins (IIb and IIIa) are separated. The heterodimer GPIIb/IIIa, 
which is the active form of the complex, is formed only after the stimulation of 
the platelet and in the presence of calcium ions. Afterward platelets expose this 
active form of the complex which is able to bind fibrinogen, in turn binding to 
the glycoproteic receptors of surrounding platelets (Gentry, 2000). 
Inside the granules there is a high concentration of molecules capable of 
maintaining and amplify the aggregation, which is limited to few platelets at 
first. ADP, Ca
++
, serotonin, fibrinogen, thrombospondin, and the thrombin 
generated by the concurrent activation of coagulation are all powerful agonists 
of platelets‘ aggregation. Platelets‘ surface is in fact provided of receptors for all 
of these molecules which induce a strong biochemical response. Other agonists 
are the molecules newly synthetized by activated platelets (PAF – platelet 
activating factor – and thromboxane A2). All of these act together to speed up 
the formation of an insoluble platelet aggregate: they promote activation and 
cohesion of platelets recruited from the blood stream to tie to those already 
attached (Gentry, 2000). 
Thrombospondin increases the dimension of platelets‘ aggregates; it has been 
proposed that it would work by producing a cross-linking to stabilize the 
aggregates of platelets and fibrinogen, or that it would co-work with fibrinogen 
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in positioning itself as a bridge among the glycoproteic complexes GPIIb-IIIa on 
the surface of platelets (Gentry, 2000). 
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GROWTH FACTORS 
 
 
Growth factors are small polypeptides synthetized by various types of cells 
belonging the immunitary and muscular-skeletal systems. Growth factors bind to 
specific cell receptors to start cycles of intracellular transduction of the signal 
and stimulate the production of proteins involved in wound healing. Every 
single growth factor has a different effect on different cells in the lesion 
environment. Some factors regulate the expression and the concentration of 
other factors through feedback responses both autocrine and paracrine. These 
modulations mainly happen thanks to the power to modulate the expression of 
cell receptors and their affinity (Woo et al., 2000). 
Extracellular signals deriving by growth factors and other active molecules 
activate the membrane. Afterwards the signal is transduced by the tyrosine 
kinase receptor. The cells of tissue, stimulated by various PDGFs activate 
enzymatic chains of signal transformation, trespassing the eventual lack of 
amplification cascade in the cases of old age and pathological processes in 
progress. This mechanism gives a possible explanation to the massive effects of 
the application of platelet derivatives on soft tissues‘ lesions (Borzini and 
Mazzucco, 2005). 
The contribution of growth factors is complied with the regulation of cellular 
metabolism, the division, the migration and differentiation of cells, the 
expression of proteins and the production of enzymes. Potentially they have the 
capability to make wounds heal, as they stimulate angiogenesis and cell 
proliferation, influence the production and degradation of the extracellular 
matrix, and they also have chemotactic action towards inflammatory cells and 
fibroblasts (Komarcevic, 2000). 
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Growth factors are nearly innumerable. The factors that have been studied more 
are: 
 Epidermal growth factor (EGF) 
 Transforming growth factor BETA (TGFβ) 
 Insulin-like growth factor (IGF) 
 Platelet-derived growth factor (PDFG) 
 Basic fibroblast growth factor (bFGF) 
 Vascular endothelial growth factor (VEGF) 
 Platelet factor 4 (PF-4) 
 Brain derived neurotropic factor (BDNF) 
 Interleukins (ILs) 
 Colony-stimulating factor (CSF). 
The concentration of growth factors in the site of lesion varies in time; this gives 
a sign on how complex is the process to ―arrange‖ a wound healing 
(Pietramaggiori et al., 2006). 
Acute lesions contain numerous growth factors that have a crucial role in the 
initial phases of wound healing. A well balanced environment is established to 
achieve scarring quickly and easily. With the chronicization process this balance 
is lost. Many studies have evaluated the iatrogenic application of growth factors 
on cutaneous chronic lesion. Knighton demonstrated that the topic application of 
various growth factors (PDGF, TGF-β, PDAF, PF4, PDEGF) could improve the 
quality and speed up the wound healing in an uncontrolled way (Komarcevic, 
2000). Similarly growth factors intervene in the healing of tendons and 
ligaments promoting cells proliferation and differentiation, increasing the 
synthesis of extracellular matrix and stimulating angiogenesis. 
The growth factors that have been more thoroughly studied for their 
involvement in the healing process of tendons and ligaments are the PDGF, the 
IGF-1, the TGF-β, the VEGF and the bFGF (Virchenko et al., 2006). 
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These factors can be potentially produced both by intrinsic cells (i.e. epitendon) 
and by extrinsic cells (i.e. macrophages); they often have dose-dependent 
effects, require specific receptors to work, and usually act in synergy with other 
signal-molecules (Molloy et al., 2003). In vivo researches have shown how the 
genic expression for IGF-1 and TGF-β1 is decreased in the initial phases of 
tendon healing. This suggests the possible therapeutic action of an exogenous 
implementation of them (Haupt et al., 2006). 
 
IGF-1. The molecule is made of a single polipeptidic chain homologue in 
structure to proinsuline. It is involved in the physiologic body growth and in 
healing processes. It can bind to two types of receptors: mannose-6-phosphate 
type 1 and 2. Specific binding proteins tie IGF-1 keeping it in ad inactive form 
and protecting it from degradation. Probably the reserve of IGF is kept in 
extracellular environment up to the income of a tissue damage, when the release 
of enzymes frees the factor activating it. 
IGF-1 is an important mediator in every phase of the healing process of a 
wound, especially during the inflammatory and proliferative phases. It favors 
fibroblasts migration and proliferation to the site of lesion, and later on it 
increases the production of collagen. Its action of promoting cell proliferation is 
amplified by the presence of other growth factors, as PDGF-BB. In vitro studies 
have shown how the mitosis, thus the cell division, of fibroblasts and superficial 
cells of tendons are strongly increased when both the growth factors are applied, 
compared to their application alone. 
In vivo studies on rats have shown the capability of IGF-1 to reduce 
inflammation and the normal functional deficit that follows a tendon lesion. 
Even if the exact mechanism through which IGF-1 modulates inflammation is 
unknown, the hypothesis is that a feed-back response is built up where high 
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concentrations of this factor would inhibit the cellular genes responsible for the 
inflammatory cascade in the site of lesion (Molloy et al., 2003). 
Among growth factors only IGF-1 has been studied for clinical use in equine 
medicine. It has been demonstrated that a series of intra-tendinous injections of 
IGF-1 can improve the healing of a collagenase-induced tendonitis. There aren‘t 
any collateral effects following the injection of IGF-1, which seems to also have 
a powerful anti-inflammatory effect just like an anabolic one. The only 
inconvenient of such therapeutic option is due to limited access to IGF-1 itself 
thus it is still used for research purposes. IGF-1 is available as a lyophilized 
powder to be reconstituted with sterile saline solution and stored at -80°C. The 
treatment consists in a series of 3 or 4 injections every 3 days (Dahlgren, 2009). 
 
TGF-β. There are three homodimeric isoforms (β1, β2, β3) each one of which 
has its own proper phenotype. They are produced by many cells involved in the 
healing process and they bind to three different classes of membrane receptors 
(RI, RII, RIII). The bond with the receptor allows the factor to carry out its own 
job. The expression of TGFβ-1 mRNA quickly increases after a tendon lesion 
occurs and it is believed to play a fundamental role in the initial inflammatory 
response of the damaged tissue. Lactate is one of the mediators more 
precociously involved in wound healing: some studies show how the cellular 
production of TGFβ-1 is directly stimulated by it (Molloy et al., 2003). 
Once activated, TGF-β influences the various aspects of tissue repair: it 
promotes cellular differentiation and proliferation (Carter et al., 2002). Klein 
demonstrated that all three isoforms of TGF-β produced some effects on the 
proliferation of collagen and cells (Klein, 2002). 
The group of TGFs is considered the first responsible for the development of 
cutaneous exuberant scars, especially the isoforms β-1 and β-2. TGF β-3 has 
been more lately described and could have an inhibitory function on the 
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formation of the scar, being a natural antagonist of TGF β-1 and -2 
(Komarcevic, 2000). 
TGF-β works in synergy with other growth factors. In vitro studies on 
fibroblasts derived from dog cranial cruciate ligaments have demonstrated that 
low doses of TGFβ-1 facilitate the isomer PDFG-AB in stimulating the 
proliferation of fibroblasts, while high concentrations have the opposite effect. 
In vivo studies have furthermore shown that high levels of TGF β-1 increase the 
development on adhesions in the tendon (Molloy et al., 2003). 
 
VEGF. There are various isoforms all with the same biological activity. The 
receptors they bind to are three and present great affinity with tyrosine-kinase 
(VEGFR-1, -2, -3). The main functions of VEGF are guaranteed by the bond 
with VEGFR-2. 
Even if VEGF has some kind of role in the initial migration and proliferation of 
cells, it reaches the highest concentrations only after the inflammatory phase 
when it manifests its great angio-genetic power. The gene expression of VEGF 
increases in response to biological and biomechanical stimuli like hypoxia, other 
growth factors, interleukins and bone distraction (Molloy et al., 2003). 
 
PDGF. It is a group of dimeric polypeptides (PDGF-AA, PDGF-AB, PDGF-
BB) formed by three types of subunits similar in their structure. Their activity is 
mediated by the interaction with two receptors close to the tyrosine-kinase, one 
of which binds all three kinds of PDGF chains while the other one can bind only 
one. 
PDGF is produced right after the tendon is damaged and at the same time it 
induces the production of other growth factors like IGF-1. It also has a role in 
remodeling the tissue (Molloy et al., 2003). 
87 
  
In vivo studies on the application of PDGF on ligament lesions have ascertained 
an increase in the strength and the stiffness of the ligament itself, while the 
application of PDGF+IGF-1 or PDGF+bFGF has not brought any improvement 
compared to those seen in controls (Molloy et al., 2003). 
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Chapter 2 
 
Platelets‘ Concentrates 
 
 
 
Platelet rich plasma (PRP) is an autologous platelet concentrate obtained by 
processing whole blood and containing red and white blood cells, plasma and 
platelets (Dahlgren, 2009). Because of the presence of so many platelets it is 
considered a vehicle and source of growth factors (Van Den Dolder et al., 2006). 
In the last decades a significant attention has been put on platelets concentrates 
and great expectations have risen about these products as platelets‘ α-granules 
contain a huge number of growth factors many of which have quite positive 
effects in the healing process of tissues. PRP has been studied for its potential 
benefits on all sorts of tissues, including tendons and ligaments more recently. 
Platelets have been studied and used either plainly as platelet concentrate, like 
PRP, or as a jelly product (platelet gel, PG) or as platelet lysate; these last two as 
a derivation of PRP. The term gel has been used to describe a jelly-like product 
which results from the addiction of thrombin and calcium to the PRP to provoke 
the break of fibrinogen. Fibrin is formed and its polymerization produces a gel 
slightly sticky and pasty. Platelets are trapped in the gel and activate releasing 
their bioactive molecules. These factors are temporarily held in the gel but 
afterwards they slowly diffuse in the surrounding area. 
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The term lysate is used to describe a liquid product obtained both by platelet 
activation through thrombin addiction and by platelet lyses after a freezing-
thawing process. The term lysate, though, is preferably used to refer to the 
product obtained by freezing and thawing of platelets, while the thrombin 
addiction produces what should be called relysate (Borzini and Mazzucco, 
2005). Platelets lyses, thus the release of their factors, is achieved when they are 
stored at -80°C and then thawed at 37°C. The lysate is also used as a scaffold 
mean to apply stem cells. This combination of products has shown brilliant 
results in vitro (Del Bue et al., 2007). Clinical studies have demonstrated the 
positive effect of the application of platelet concentrates on the healing process 
of hard and soft tissue. 
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PRP APPLICATIONS IN HUMAN MEDICINE 
 
 
Platelet concentrates are used in odontoiatry, in maxilla-facial surgery, and 
recently also in diabetic patients with serious skin ulcers and in plastic, 
reconstructive, ophthalmologic and orthopedic surgery (Anitua et al., 2004; 
Virchenko et al., 2006). The use of platelet concentrates was demonstrated to 
reduce the need for drainages and elastic or compressive bandages, along with 
reducing the incidence of complications, infections and hospitalization time. 
PRP has anti-inflammatory, bactericide and hemostatic properties. It also is used 
in many surgical procedures, as the lumbar arthrodesis, the reduction of 
complicated bone fractures, the repositioning of joints after luxation, 
arthroscopic treatment of traumatic osteo-chondral defects, treatment of the 
Achilles tendon‘s lesions, intrarticular treatment of osteoarthritis. PRP is used 
also to repair the retina of patients affected by idiopathic macular holes (Anitua 
et al., 2004). 
 
Use in odontoiatry and maxilla-facial surgery. In 1997 Whitman and 
colleagues first reported the effects of platelet gel to speed up healing after oral 
surgery. One year later Marx et al. used the PRP in combination with autologous 
bone implants to rebuild mandibles affected by loss-of-substance. Their study 
demonstrated that this therapeutic option could achieve a faster maturation of 
bone and a higher density of the matrix compared to the bone implant alone 
(Marx et al., 1998). Since then the effects of PRP on bone regeneration have 
been widely studied (Whitman et al., 1997; Kassolis et al, 2000; Camargo et al., 
2002; Lekovic et al., 2003; Nikolidakis et al., 2006) and PRP has been used for 
many clinical procedures in odontoiaatry (Plachokova et al., 2008). 
91 
  
In 1999 Anitua performed a study on 20 odontoiatric patients. Some of them had 
vertical fractures and dental extraction had been indicated as the only possible 
option to solve the problem; other patients had severe periodontal pathologies to 
be solved by positioning an implant. Ten of these patients were treated with 
topic treatment with GFRP (Growth Factors Rich Plasma) while other ten were 
used as controls. The results obtained in the GFPR patients were of an excellent 
rehepitelization, an almost complete regeneration of the treated area, the 
formation of trabecular bone organized and mature. The control group showed a 
good reparation of the damaged area but the loss of substance was filled in with 
connective tissue, and only a few cases had mature bone (Anitua, 1999). 
Use in plastic surgery. The use of autologous platelets in reconstructive and 
facial plastic surgery has ported many advantages: there is a general decrease of 
operative time, need for drainages, compressive bandages and incidence of 
complications. Valbonesi performed a study on 14 patients affected by either 
traumatic or pathologically chronic loss of soft tissues and skin and reported a 
reduction of post-operative infections and time of hospitalization. 
The anti-inflammatory properties of platelets concentrates were also 
demonstrated in a study on 8 women undergoing facial lifting, and that showed a 
lower rate of edema and ecchymosis (Anitua et al., 2004). 
Use for treatment of ulcers. In 2002 Tarroni and colleagues successfully used a 
platelet gel obtained by the activation of two traditional hemo-derivatives: a 
platelet concentrate and the cryo-precipitated activated with an enzyme with 
coagulant action, batroxobine, with the addiction of chloride calcium. The 
product was applied on a chronic ulcer on a foot of a 62 years old man. The 
ulcers recovered after 8 applications and the foot had not to be amputated any 
more. 
The application of a platelet lysate as a source of growth factors was of great 
success also in a patient affected by β-thalaxemia with an ulcer older than 4 
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years on his ankle. Complete recovery was achieved in one month (Anitua et al., 
2004). 
Use in orthopedic surgery. There is a number of studies in this field (), the 
most interesting of which regard the spine. Autologous concentrates of growth 
factors have been used in patients supposed to undergo lumbar arthrodesis with 
encouraging outcomes. Lowery and colleagues performed a study on 39 
patients, 19 of which were followed up for 6 months. Among these 5 showed a 
steady fusion of the bones (Anitua et al., 2004). 
Treatment of tendons and ligaments. In recent studies Anitua demonstrated 
that the injection of autologous PRP and calcium facilitated the regeneration of 
the anterior cruciate ligament and the reattachment of the articular cartilage of 
the knee in humans. The fundamental role of endogenous growth factors (like 
the IGF-1, TGF-β, VEGF, PDGF, and bFGF) in the healing of tendons and 
ligaments has been documented: these factors in fact take part to the 
inflammatory, proliferative and remodeling phases of the tissue. Furthermore 
Anitua experimented the use of autologous platelet concentrates activated with 
calcium for the reparation of muscle ruptures and of the Achilles‘ tendon with 
satisfactory results (Anitua et al., 2004). 
Use in ophthalmic surgery. Another surgical field where the positive effects of 
platelets concentrates have been reported is ophthalmology. In 1999 Gehring 
and colleagues applied an hyper concentrated platelet product to treat macular 
retinoic holes achieving a quicker closure. Hartwig and colleagues more recently 
(2004) have applied PRP on corneal epithelium defects (Borzini and Mazzucco, 
2005). 
In a study, 110 French patients have been subjected to surgical treatment to 
reduce idiopathic macular holes and half of them have been injected with 
autologous platelet concentrate during the treatment. One month after surgery 
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the anatomic success of the closure of retinoic holes was significantly higher in 
the PRP treated patients (Anitua et al., 2004). 
Potential risks of the use of PRP in human medicine. Platelets release low 
molecular weight compounds that can diffuse. They also release a great number 
of micro-particles that carry pro-thrombotic proteins (like TF and Il-1β). The 
application of platelet concentrates nearby blood vessels must be very careful, 
especially in patients at risk of thrombosis. The contemporary use of anti-
aggregation drugs may theoretically reduce the risk of development of 
thrombosis, but further studies are still needed on this topic (Anitua et al., 2004). 
The preparation of platelet concentrates must be performed in proper transfusion 
centers to respect asepsis and security standards to avoid the risk of infection. 
Anyways no cases of infected wounds after platelet gel application have been so 
far reported. 
The risk of an immunitary reaction or transmission of infectious diseases (i.e. 
hepatitis and HIV) must be excluded because the product is autologous. 
Even if growth factors have mitogen properties there is no evidence they may 
promote development of tumors or have cancerogenous power. Scott and 
Pawson have also demonstrated that growth factors act on cell membranes and 
not on the nuclei; furthermore the gene expression induced by growth factors 
doesn‘t present any anomaly (Everts et al., 2006). 
Studies on animal models. The studies about PRP application on animal models 
confirm the results obtained in humans (Anitua et al., 2004). 
Anitua and Ortiz performed a study on goats using titanium implants covered by 
PRP and obtained improvements both in the quality and the quantity of 
regenerated bone tissue around the implant (Anitua et al., 2004). 
Histologic studies on bone defects around titanium implants in dogs have proven 
that PRP increases the local production of bone (Kim et al., 2002). With human 
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PRP the distance between the pores of hydroxyapatite could be reduced 
(Siebrecht et al., 2002). 
The application of PRP in ligaments was proposed for dogs with cranial cruciate 
ligament rupture and in rats with patellar ligament lesion (Dahlgren, 2009). 
A study on muscular tissue reported consistent results of muscle regeneration in 
rabbits treated with PRP (Jodezyk et al., 1986). In another study lesions of the 
femur trochlear cartilage were induced in rabbits and the intrarticular injection 
of PRP favored the formation of a tissue maintaining the viscoelastic features 
proper of the original cartilage tissue (Serra et al., 2006). 
Cullinane and colleagues demonstrated that treatments with platelet concentrates 
improved the cell proliferation in the healing of retinoic lesions in rabbits 
(Anitua et al., 2004). 
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APPLICATION OF PRP IN HORSES 
 
 
Use in orthopedic surgery. In a preliminary study platelet gel was applied in 
two horses with a vertical fracture of the navicular bone. The PG was applied on 
the line of fracture and after 4 months radiographic controls showed the 
complete recovery. In a filly with an olecranon fracture and subjected to PG 
application two weeks after the osteo-synthesis surgery the healing of the bone 
was complete and uneventful (Spadari et al., 2006). 
Treatment of skin wounds. In the treatment of skin lesions the application of 
PRP resulted in an increase of formation of granulation tissue, fibrous tissue and 
epithelium. Carter and colleagues have compared the time and quality of the 
healing of skin wounds treated with local application of jelly PRP and non-
treated wounds. The analysis of bioptic samples has demonstrated how the PRP 
induced a faster differentiation of the epithelium and a greater production of 
collagen with braided strands and better organization. Seven days after lesions 
the treated tissues were more epithelized than the controls and after 79 days their 
collagen had more parallel fasces, while in the control they were fewer and 
randomly oriented (Carter et al., 2003). 
Monteiro and colleagues proposed again the use of PRP on surgically created 
skin wounds in the distal portion of the limbs of 6 horses. PRP induced the 
development of an excessive quantity of granulation tissue and the healing was 
significantly slowed 1, 2, and three weeks after surgery. Monteiro deduced that 
the local application of PRP did not accelerate or improve the healing of small 
wounds of limbs in horses but he sustained its application for lesion with 
massive loss of substance or chronic wounds (Monteiro et al., 2009). 
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Prp in equine teno-desmic lesions. The available data about the use of PRP in 
tendon and ligament lesions in horses are still too few; thus nowadays it is only 
possible to suppose the intra-lesional injection of such product can supply the 
damaged tissue with a large amount of growth factors and support the healing. 
To recommend the use of platelet concentrates to treat equine tendinopathies a 
lot of issues must be taken into consideration: the choice of the method of 
preparation, the eventual need to activate platelets at the time of injection, the 
quantity of growth factors to make it effective in promoting the regeneration of 
the tissue (Dahlgren, 2009). 
Many in vitro studies have been performed. Tablin and colleagues studied the 
effect of platelet growth factors (obtained from supernatant frozen with dry ice 
and then rehydrated) and applied on fibroblast cell cultures. The obtained results 
were an improvement of the proliferation and migration of fibroblasts and an 
increase in the production of collagen (Tablin et al., 2008). 
PRP improved the gene expression of type I and type III collagen and of COMP 
when used in vitro on SDFT explants (Dahlgren, 2009). 
Other studies on cultured fibroblasts deriving from SLs have shown the PRP 
ability to increase the synthesis of COMP and other proteins (Schnabel et al., 
2008). 
Haupt and colleagues instead applied a human growth factor (PDGF-BB) on 
equine tendon explants. They observed an increase in type I collagen and a 
temporary increase of the expression of PDGF-BB itself. The study lasted 6 
days and the registered effects were very limited compared to the total content 
of collagen of SDFTs (Haupt et al., 2006). 
The good perspectives designed by in vitro studies have led to in vivo trials. 
Waselau and colleagues treated with intra-lesional injection of PRP 9 
standardbred horses affected by SL desmitis. After treatment a fitting 
rehabilitation protocol was set up and the horses got back to racing. Their start-
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ups, the total wins and the wins per start-up were compared to those obtained by 
an equal pool of horses not treated with PRP. The results obtained were quite in 
favor for the first group, especially in the second year of racing but the study 
was unable to discriminate whether if the positive outcome had to be attributed 
to the PRP treatment, to the rehabilitation protocol, or to a combination of the 
two things (Waselau et al, 2008). 
Arguelles and colleagues used PRP in 2 horses affected by acute SDFT 
tendonitis and 3 with a chronic proximal SL desmitis. An ultrasound-guided 
intra-lesional injection was performed 3 times every two weeks. Horses were 
clinically controlled after 2, 12, and 20 months after injection. Clinical signs and 
ultrasound appearance were taken into consideration for a complete evaluation. 
The ultrasound appearance improvement regarded mainly the horses with SDFT 
lesions; in any case all horses improved clinically and got back to racing in a 
short time (2 to 6 months after treatment) without relapsing within the 20 
months of the study (Arguelles et al., 2008). 
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QUANTIFICATION OF GROWTH FACTORS IN PRP 
 
 
The knowledge of the quantity of growth factors available in PRP is highly 
predictive to outline the prognosis for the subject to be treated, thus of great 
importance for a proper clinical use. Unfortunately there are no available 
procedures at this time to have an esteem on the amount of growth factors 
present and biologically active in a PRP sample. Neither the whole blood nor the 
platelet count can help in understanding the GF concentration in the platelets of 
an individual. The GF present in platelets of mammals are basically of the same 
kind among species, but there is a difference in their relative concentration. 
Furthermore, each subject has a different total amount of GFs, even if they are in 
proportion according to the specie. 
In a study on human blood samples, after proper centrifugation and automatic 
separation of the fractions, the quantification of some GFs (PDGF, TGF-β1 and 
2, IGF-1) was obtained using specific ELISA kits (Quantikine Elisa Kit, R&D 
Systems). The analysis of variance for the PDGF-AB, PDGF-BB, TGF-β1 and 
TGF-β2 showed that there is no correlation at all with sex or age and the 
quantity of growth factors. Only the levels of IGF-1 seemed to be slightly lower 
in older patients. A high variability among subjects has thus been recognized, 
and the relation for the quantity of GFs and other individual biological factors 
yet to be discovered has been suspected (Weibrich et al., 2002). 
Weibrich and colleagues sustain that the platelet concentration in human PRP is 
related to the platelet count of the whole blood (Van Den Dolder et al., 2006). 
In a comparative study, PRP from humans, rats, and goats were compared. The 
result was that human PRP contains higher concentrations of GFs than the other 
two species. Furthermore, goat‘s PRP has more GFs than the rat‘s, exception 
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made for the PDGF-BB which is more concentrated in rat‘s PRP. These result 
may then somehow justify the difficulty obtained in achieving clearly positive 
results of PRP application in animal models (Van Den Dolder et al., 2006). 
 
Platelet count. The normal number of platelets in human blood varies between 
150,000 and 350,000/mm
3
. A concentration of 1,000,000/mm
3
 in 5 mL of 
plasma could be considered the ideal concentration of platelets for an effective 
human PRP: lower concentrations haven‘t brought any improvement to wound 
healing, while higher concentrations do not achieve proportionally higher results 
(Van Den Dolder et al., 2006; Everts et al., 2006). 
The reported concentrations of platelets in equine PRP vary a lot among studies. 
Carter and colleagues successfully used a PRP produced by apheresis with a 
platelet concentration of 490,000/mm
3
 platelets (Carter et al., 2003). Sutter 
obtained a 855,000/ mm
3
 platelet concentrate with the apheresis method and a 
1,472,000/ mm
3
 platelet concentrate using the buffy coat system. 
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ACTIVATION OF PRP 
 
PRP itself is an inactive product because the growth factors are stored inside the 
α-granules of the cytoplasm. Activation of PRP can be achieved with the aid of 
many different bioactive molecules; among these, thrombin is the most powerful 
one. Thrombin is a protease of the serum involved in the coagulation process; 
although, it has many other biological properties similar to those of growth 
factors: it has chemotactic action toward neutrophils, monocytes and 
macrophages, it stimulates fibroblasts‘ proliferation, accelerates wound healing. 
In vitro studies suggest that thrombin‘s role in the healing process is separated 
by its role in coagulation. Thrombin is responsible for the conversion of 
fibrinogen into fibrin. Its action is allowed thanks to the bond with specific 
superficial cell receptors that can activate proteases while the non-protolithic 
portions of the molecule can activate other receptors (Virchenko et al., 2006). 
Bovine thrombin is the most commonly used in practice but its application in 
humans has been correlated to the development of antibodies against some 
coagulation factors (V, XI) eventually resulting in a coagulopathy (Landesberg 
et al., 2000). To overcome to this problem a synthetic product, batroxobine, has 
been afterwards used. 
Batroxobine is a thrombin-like enzyme that induces jellification in a different 
way than thrombin does. While thrombin activates platelets, thus induces a 
quick release of growth factors and accelerates the retraction of the coagulum, 
batroxobine traps the platelets in a net of fibrin without activating them. For this 
reason the release of growth factors and the retraction of the coagulum happen 
slowly, in a gradual process. Batroxobine, differently from thrombin, doesn‘t 
stimulate the immunitary system and is not inhibited by heparin. It has also been 
demonstrated that the survival and the availability of cytokines released by 
platelets change depending on the type of polymerization of fibrin. The use of 
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batroxobine other than thrombin is especially preferred in those cases where 
growth factors are strongly preferred to stay in the site of lesion for a long time 
(Mazzucco et al., 2008). 
In disguise of thrombin calcium chloride can be preferred: it is an inert 
substance thus it cannot induce any immunitary reaction (Arguelles et al., 2006). 
The use of thrombin and calcium together induces the production of a jelly 
substance called platelet gel (PG) (Zimmermann et al., 2008). 
The levels of GFs are influenced by the degree of platelets‘ activation, thus they 
may change depending on the substance used to activate them (Zimmermann et 
al., 2003; Tablin et al., 2008). 
Another way to induce platelet activation is freezing (-80°C or -196°C). This 
irreversible activation is known as ―cold lesion‖ and can be avoided with a 
process of biochemical stabilization using amiloride, adenosine and sodium 
nitropruxiate (Pietramaggiori et al., 2006). The method consists in freezing the 
platelet concentrate and then thawing it at 37°C. This physical treatment induces 
cell membranes to break and release the chemotactic and growth factors without 
needing further activation (Del Bue et al., 2007). 
The release of GFs from the granules is never complete, neither after the 
formation of the coagulum nor after freezing-induces lisys. This might be due to 
the presence of platelets‘ micro particles (PMPs), which are small fragments of 
the platelet membrane, and of WBCs deriving micro particles. Micro particles  
seem to contain growth factors that cannot be detected with immunologic 
techniques (Zimmermann et al., 2003). 
Another way to jellify PRP is the use of ITA jelling agent (Natrex Technologies 
Inc., Greenville, NC). This method requires simpler material and can be used 
also in ambulatory environment (Landsberg et al., 2000). 
102 
  
For human medicine ready-to-use kits have been produced: they supply the 
activators for the platelet concentrate and often also the instruments to 
aseptically inject the product (Smart PreP2 by Harvest, Plateltex). 
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METHODS FOR THE PREPARATION OF AUTOLOGOUS PRP IN 
EQUINE MEDICINE 
 
The traditional methods to prepare platelet concentrates are: a) the buffy coat 
method; b) the platelet rich plasma method; c) the apheresis. Nowadays there are 
many systems available to prepare PRP that cannot be classified in any of these 
categories. The simplest possible classification is to them in automatic and 
manual methods. Manual systems (buffy coat and apheresis) are those where the 
operator can see the interface plasma-red blood cells  having the possibility to 
modify the procedure based on the single case (Sutter et al., 2004). 
1) Buffy coat method. Fifty milliliters of blood are collected from the 
jugular vein with a 12G needle into a citrated blood-tube with valves for 
the separation of blood fractions. The tube is centrifuged at 2100g per 9 
minutes in a special centrifuge with a support for the tube. The fraction 
with the red blood cells is afterwards extracted from the bottom through a 
blood port, leaving exactly 3 cm of RBC and platelets packed in the tube. 
The tube is then centrifuged again at 2100g per 3 minutes. The plasma is 
afterwards discharged through the plasma port  which is set to leave in 
situ 5 milliliters of product (10% of the initial volume) that contain the 
final product (Sutter et al., 2004). 
2) Apheresis method. An apheresis system is used to obtain the platelet 
concentrate with a process of discontinuous centrifugation. A bowl set 
with a basic volume of 125 milliliters is installed into the apheresis unit 
and connected to blood separation bag with a scaled tube. In the 
separation line there  are three bags: one for the plasma, one for the buffy 
coat, and one for the air. The bowl set is connected to the blood bag of the 
donor. The apheresis unit is initially set at 5650 rpm, with a pumping rate 
of 60 ml/min. The donor bag is rocked in continuous to prevent 
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sedimentation of RBC. The bowl is filled in until the RBC reach a preset 
level; at this point the platelet poor plasma (PPP) enters the plasma bag 
and the pump stops. The centrifugation speed decreases to 2400rpm and 
the tap of platelet concentrate and the plasma bag are opened. At this 
point the pumping unit is reactivated and 3mls are pumped in the bag of 
the buffy coat. The pump is turned off for 10 sec before it is turned on 
again to pump 3 more milliliters of platelet concentrate in the collection 
bag. This process of platelet extraction continues until 45 ml of 
concentrate have been obtained (Sutter et al., 2004). 
3) Method of filtration after apheresis. The concentrate obtained with 
apheresis is concentrated again with a 30 KD pores filter that filtrates 
water and low molecular weight molecules. The 45 ml of concentrate 
gained with the apheresis are pumped through the filter in both directions 
to reduce the volume to the final 15 ml (Sutter et al., 2004). 
Comparison between results of methods 1, 2, and 3 and whole blood. The 
time and the costs of apheresis method are higher than the buffy coat one, but 
the possibility of bacterial contamination is lower. The apheresis technique 
followed by filtration registered the higher degree of platelet concentration in 
horses: it reaches a 13 times fold, against the 8.9 of the buffy coat and 5.2 of the 
apheresis compared to the platelet count of whole blood. The buffy coat system 
though starts with a small quantity of blood (50 ml) thus the obtained PRP is 
little compared to the other methods. 
The levels of TGF-β1 of the buffy coat PRP aren‘t very different from those 
obtained with apheresis, whilst apheresis concentrates more the TGF-β2. The 
concentrations of IGF-1 are not increased compared to the whole blood, and 
they are way lower in the buffy coat PRP than in the apheresis PRP or in whole 
blood. 
With apheresis there are many more less RBCs thus a lower hematocrit. The 
effects of RBCs in the platelet concentrate are yet to be investigated but they 
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would certainly be a problem having to use the product in a different subject 
other than the donor (Sutter et al., 2004). 
 
4) Method of the single centrifugation (tube method). Forty milliliters of 
whole blood are harvested by jugular venipuncture with a 23G butterfly 
needle in sodium citrate. The 40 ml of citrate blood are collected in 8 
tubes with 5 ml each; they are then centrifuged at 120g per 5 min. Two 
fractions of platelet concentrate are obtained: PC-A and PC-B. PC-A is 
arbitrarily considered the 50% of the supernatant just above the buffy 
coat, and the PC-B the 50% over the PC-A. Five ml of each PC are 
separately put in 10 ml polypropylene tubes. 
In preliminary studies to set up this protocol Anitua‘s centrifugation 
schedule was followed, which is at 460g per 8 min. Afterwards it 
demonstrated inapplicable in equine medicine as the effect on 
sedimentation of equine platelets is different from that of human platelets 
(Arguelles et al., 2006). 
5) Method of the double centrifugation (tube method). Eighty milliliters 
of whole blood are harvested by jugular venipuncture with a 23G butterfly 
needle in sodium citrate. The 80 ml of citrate blood are collected in 16 
tubes with 5 ml each; they are then centrifuged at 120g per 5 min. The 
PC-A fraction (averagely 20 ml) is collected from each tube and put in 
two 10 ml tubes. This fraction is centrifuged at 240g per 5 min. The 
centrifuged PC-A is then arbitrarily divided in two fractions: PC-C and 
PC-D. The PC-C is the lowest 25% of the centrifuged PC-A and the PC-D 
the remaining 75% (Arguelles et al., 2006). 
Comparison of the methods 4, 5 and whole blood. In equine blood after a 
single centrifugation (120g per 5 min) platelets and white blood cells are 
distributed almost uniformly in PC-A and PC-B. The results obtained by Anitua 
on human blood instead presented a higher concentration of platelets in the 75% 
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of the plasma thus Anitua called it growth factors rich plasma and the remaining 
25% growth factors poor plasma. This is why Anitua‘s protocol to obtain a good 
platelet concentrate from equine blood, while the buffy coat and the apheresis 
methods can be as well used for horses without modifications (Arguelles et al., 
2006). 
The levels of TGF-β1 calculated in the PCs result higher compared to the 
starting whole blood. In PC-B and PC-C the levels are similar and higher than 
PC-A and PC-D. The levels of TGF-β1 are not related to the platelet count or the 
number of white blood cells. 
The levels of MPV (Medium Platelet Volume), MPC (Medium Platelet 
Concentration) and MPCDW (Medium Platelet Concentration Distribution 
Weight) calculated with a hematologic flow cytometer in the PCs of both 
methods result to be very different: much higher levels are in the PCs after 
single centrifugation, while after double centrifugation they are low and similar 
to the starting whole blood. 
PCs obtained with one centrifugation have significantly higher level of platelet 
activation compared to double centrifugation PCs and whole blood. It can then 
be stated that the PC-B and the PC-C are to be preferred for clinical use in 
equine patients with muscular-skeletal pathologies (Arguelles et al., 2006). 
Comparison of methods 1, 2, 3, 4, 5, and whole blood. The number of 
concentrated platelets is higher with the apheresis with filtration, followed by 
buffy coat, then by the apheresis and finally by PC-D, PC-C, PC-B, PC-A and 
whole blood. 
In the tube method leukocytes are less concentrated compared to the methods of 
the buffy coat and the apheresis. 
The concentration of TGF-β1 varies depending on the method used: it is higher 
in the apheresis with filtration to decrease progressively with apheresis, buffy 
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coat, in the PC-C and PC-B, PC-D and PC-A, with the lowest levels in whole 
blood (Arguelles et al., 2006). 
Different methods of centrifugation to obtain PRP. Many variations on the 
method of the double centrifugation are described in literature. The time and the 
speed of centrifugation proposed by authors are all different. 
Virchenko and colleagues obtained a platelet concentrate from rats: the blood 
with the anticoagulant was first centrifuged at 220g for 20 min. The supernatant 
was collected and centrifuged at 480g per 20 min (Virchenko et al., 2006). 
Landesberg and colleagues tried to obtain a higher platelet concentration from 
human blood. They evaluated the number of platelets in relation to the time and 
the speed of centrifugation and the best results were obtained with 200 g per 10 
min for both centrifugations (Landesberg et al., 2000). 
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ROLE OF WHITE BLOOD CELLS IN THE PLATELET CONCENTRATE 
 
The gradient of density of some categories of leukocytes is very close to the 
platelets‘. This is why some leukocytes, especially lymphocytes and monocytes, 
stratify along with platelets when PRP or PG are prepared, while granulocytes 
stratify with red blood cells. Thus PRP and PG contain a certain amount of 
WBCs (Zimmermann et al., 2008). Everts and colleagues point out to the wrong 
terminology used in the papers so far published about PRP and other platelet 
concentrates, where the product that is used is actually a platelet-leukocyte rich 
plasma (Everts et al., 2007). The contamination with WBCs incises on the total 
amount of growth factors but very little is yet known about the in vivo effects of 
such contamination. For sure the quote of growth factors in a platelet 
concentrate produced with common methods are not to be attributed only to 
platelets, as WBCs play a role in the release of GFs. Only applying platelet 
concentrates obtained by platelet-pheresis the effects of platelets alone can be 
distinguished by the effects of platelets and WBCs together (Zimmermann et al., 
2008). 
Another role often imputed to leukocytes in PRP is the antimicrobial activity. 
Neutrophils and monocytes are rich in granules containing myeloperoxidase, an 
enzyme catalyzing the oxidation of chlorite to produce hypo-chloric acid and 
other reactive derivatives of oxygen acting as toxic oxidant agents, thus being 
disruptive toward bacteria and funguses (Everts et al., 2007). 
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POTENTIAL RISKS OF THE USE OF PRP IN HORSES 
 
The risk of thrombosis, already reported for humans, doesn‘t represent a 
problem for horses treated with PRP, as thrombotic pathologies are neither 
likely nor frequent in this specie. Also for horses, as for humans, it is quite 
important to respect aseptic conditions in all of the phases of preparation and 
injection of the product. There are in any case no reports of post-operative 
complications due to contamination. 
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SECTION 3 
 
Use of autologous platelet rich plasma for 
tendons’ and ligaments’ injuries in horses: a 
clinical trial 
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DESIGNATION OF A PROTOCOL FOR THE 
PREPARATION OF AUTOLOGOUS PLATELET RICH 
PLASMA IN HORSES 
 
 
As previously described in literature there are at least three standardized 
methods for the preparation of PRP: buffy coat method (semi-automatic), 
apheresis system (automatic), and of the single or double centrifugation 
(manual) (Monteiro et al., 2009) each of which has been in time modified by 
different authors to the purpose. 
The system proposed in this study was designed adapting to horse blood the 
protocol used for human blood in the Laboratory of Hematology of the Rizzoli 
Hospital of Bologna, as suggested by Dr. Dallari (pers. comm., 2005). 
The protocol designed is the result of a series of attempts to refine a procedure 
that could be easy to apply, moderate in costs, repeatable, fast to perform and 
that could guarantee the wanted characteristics of the final product: high 
concentration of platelets, no contamination, low WBCs and RBCs counts. 
Thus the choice was to use a double transfusion bag with collection needle 
already inserted and membranes to separate the bags. This is a closed, sterile 
system that allows to easily process and handle the product without any possible 
contamination or contact with outer environment through the whole process. 
 
Preparation procedure 
A small squared area of the upper-mid jugular region was clipped and cleaned 
with Betadine. A subcutaneous injection of 0.5ml of 2% Lidocaine was 
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performed to reduce the itching of the collection needle. The skin was 
afterwards aseptically prepared with serial passages of a betadine solution (10%) 
and clorexidine. Skin was finally washed and dried with sterile water and 
gauzes. 
Three-hundred-fifty milliliters of whole blood were collected by jugular 
venipuncture in a double blood bad pre-filled with citrate to prevent coagulation. 
The first bag (collection bag) is connected to the needle through which the 
harvesting was performed. In this first phase the second bag remains closed. The 
collection happens per gravity, and throughout the bag is continuously rocked to 
preven  t the formation of micro-aggregates. After the harvesting, the collection 
bag was hermetically closed with plastic pins, and the skin of the horse treated 
with antimicrobial paste. 
The centrifuge used in the study (GPK Centrifuge, Beckam Instruments Inc.) is 
calibrated in RPM other than in g, thus a conversion was needed following the 
conversion formula g=11.18r (M rpm/1000)2, where g is the relative centrifuge 
force, r is the revolution ray (the distance between the particle and the rotation 
axis), N rpm is the number of revolutions per minute. The maximum ray of the 
used centrifuge was 0.19 mt. 
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After centrifugation the various hemocomponents (RBCs, plasma, platelets, and 
WBCs) stratify on the basis of their weight: RBCs at the bottom, the buffy coat 
(mainly WBCs and some platelets), platelets and then supernatant plasma. 
The bag system is the centrifuged a first time at 1000 RPM per 20 minutes. It 
has been sometimes necessary to prolong this time up to the 100% to allow a 
better separation of the fractions. The second bag is afterwards opened and the 
supernatant is pushed to flow into this second bag. The amount of buffy coat let 
into the second bag was different depending on the type of product wanted. 
After closing the communication between the two bags with metal clamps the 
second centrifugation is performed at 3000 RPM for 10 min. Afterwards the 
metal clamps are removed and the greatest amount of the content of the second 
bag is manually pushed back into the first one. The quantity that must remain in 
the second bag is the 10% of the initial volume of blood and represents the PRP. 
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The obtained PRP was finally collected in syringes and transferred in 2 ml 
sterile cuvettes (in a sterile set-up) to divide it into aliquots. A small quantity of 
it (2 ml) was used and analyzed to evaluate the quantity of platelets and WBCs 
obtained. The count was performed with an automatic analyzer -- LASER Cell-
Dyn 3500 (Abbott Diagnostics). 
 
Injection 
The injection procedure requires the clipping and aseptic preparation of the area 
where the lesion has been ultrasonographically detected. The horse is sedated 
with acetilpromazine (0.02 mg/kg), detomidine (0.02 mg/kg) and butorphanol 
(0.01 mg/kg). 
A 7.5 MHz linear ultrasound probe is covered with a sterile glove to visualize 
the lesion and perform the ultrasound-guided intra-lesional injection. A 21G 
needle is inserted into the lesion and then connected to the syringe filled with 
PRP. The insertion of the needle must be carefully supervised 
ultrasonographically to direct the point of the needle in the wished direction. 
When the procedure is carried out correctly the incidental injection of PRP in 
the in sub-cutis, in other tendons or other surrounding structure is avoided. 
The injection itself must be performed with a smooth constant pushing of the 
bucket of the syringe until the resistance is too high. Small movements of the 
needle are allowed within the lesion to fill it in properly. In case of multiple 
injections instead a new needle is needed at each time, and the insertion must be 
each time ultrasonographically checked. The injected quantity varies between 2 
and 15 ml depending on the size of the lesion and how disruptive it has been. 
After the treatment a simple soft bandage with elastic bands is put and left on for 
a couple of days. 
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Follow-up 
After the injection the horse was hospitalized for two days to control the clinical 
condition and exclude the possible occurrence of infections. 
After dismissal a rehabilitation protocol was suggested to be completed at the 
stable. Often though the referring veterinarian was assigned to schedule the 
rehabilitation protocol for the horse, limiting the possibilities to have uniform 
treatment in the rehabilitation phase. 
The standard rehabilitation protocol suggested in the study was the following: 
1
st
 week: 5 min walk once a day 
2
nd
 week: 5 min walk twice a day 
3
rd
 week: 10 min walk twice a day 
4
th
 week: 15 min walk twice a day 
5
th
 week: 20 min walk twice a day 
6
th
 – 8th week: 15 min walk and 5 min slow trot twice a day. 
 
This protocol ensures that at least for the first two months the horse is not 
pushed too hard through training. 
Each owner was requested to come back to perform a clinical and 
ultrasonographic control at the end of the two months (and also later on) but 
only a few horses were submitted to the clinic again for a complete follow-up. 
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CLINICAL CASES 
 
Twenty-one horses referred to the Service of Acceptance and Hospitalization for 
Large Animals of the Veterinary Clinical Department of the University of 
Bologna were included in the study. 
Each horse was referred by a practitioner veterinarian with suspect of distal limb 
soft tissue injury. At arrival the anamnesis was collected, including data as the 
time of insurgence, the clinical course, the clinical signs at the first visit and the 
eventual changes up to the time of referral. The anamnesis was unfortunately not 
always thorough and complete, as especially trot and race horses are managed 
by numerous people and sometimes it isn‘t possible to gather the information 
each one could give. 
In any case the horses were afterwards submitted to clinical investigation and 
ultrasonography to diagnose the lesion and, if the characteristics of the lesion 
would fit with a PRP treatment, they would be included in the study. 
The cases here reported are of horses affected by lesions of SDFT, DDFT, ICL, 
and SL both in fore and hind limbs. Lesions higher than the carpus/tarsus or 
lower than the fetlock were excluded because, as previously described, the 
characteristics of the tendons (and ligament) are too different from those of the 
metacarpal/tarsal region. 
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Case #1: Horse 020002928 
Breed: Standardbred 
Sex: Gelding 
Age: 8 y. o. 
Activity: trot races 
Anamnesis: From two weeks the horse is presenting a painful, hot swelling of 
the palmar aspect of the right forelimb. Third degree lameness. The horse has 
been suffering of tendonitis in the same limb. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). The area is still swollen, warm and slightly painful. 
The SDFT is generally hypo-echoic with altered echo-structure in the zones 2A 
and 3B. The longitudinal scan highlighted the presence of a large anechoic area 
with total absence of fibers in the zone 2B. The whole length of the tendon 
presented a serious misalignment of fibers.  
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Diagnosis: acute tendonitis (relapse) of the right forelimb SDFT. 
Therapy: ultrasound guided intralesional injection of PRP. 
PRP features: 
 Platelet count: 481000/ µl 
 WBCs count: 15600/ µl 
 Whole blood counts: PLT 147000/ µl and WBCs 8610/ µl 
Platelets had a three times fold concentration and WBCs a two times fold. 
Clinical course: the horse was submitted to a rehabilitation protocol for 4 
months. Got back to race and after 3 start ups the pathology relapsed with the 
same characteristics. 
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Case #2: Horse 020002952 
Breed: Standardbred 
Sex: Male 
Age: 6 y. o. 
Activity: trot races 
Anamnesis: From some days the horse is presenting a moderate swelling of the 
palmar aspect of the right front metacarpus. Slight lameness. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (1/5 degree). The area is still slightly swollen. 
The SDFT is presents a core lesion in the zone 2A. In longitudinal scan the 
lesion has a CSA of 37.6mm
2
 (75% of the whole tendon; score 2/3), while it is 
2.3cm long in longitudinal scan. The tendon has a slightly hypo-echoic aspect in 
the area surrounding the lesion. 
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Diagnosis: acute tendonitis of the right forelimb SDFT. 
Therapy: ultrasound guided intralesional injection of PRP. 
PRP features: 
 Platelet count: 706000/µl 
 WBCs count: 18700/µl 
 Whole blood counts: PLT 70700/ µl and WBCs 4810/ µl 
Platelets had almost a ten times fold concentration and WBCs almost four times 
fold. 
Clinical course: the horse was submitted to a rehabilitation protocol for almost 
6 months. Got back to competition at the same previous level. After some 
months it was sold and the final outcome is unknown. 
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Case #3: Horse 020002969 
Breed: Holstein 
Sex: Gelding 
Age: 5 y. o. 
Activity: jumping 
Anamnesis: the horse is referred for chronic lameness of the left forelimb, 
intermittent for gravity. The suspect is of a chronic left forelimb SL desmitis. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (1/5 degree). 
In longitudinal scanning the SL presents dishomogenous echogenicity and 
increased thickness, starting from zone 1B. 
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Diagnosis: chronic desmitis of the left forelimb SL. 
Therapy: ultrasound guided intra-lesional injection of fresh PRP. 
PRP features: 
 Platelet count: 735000/µl 
 WBCs count: 4570/µl 
 Whole blood counts: PLT 109000/µl and WBCs 7400/µl 
Platelets had almost a seven times fold concentration and WBCs almost halved. 
Clinical course: the horse was kept in stable for one week and started a 4 
months rehabilitation protocol. Got back to competition at the same previous 
level. After two months the horse injured seriously during a competition but the 
lesion did not involve at all the previous pathology. 
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Case #4: Horse 0200003066 
Breed: Standardbred 
Sex: Male 
Age: 3 y. o. 
Activity: trot races 
Anamnesis: the horse is referred for lameness of the right hind limb from a 
couple of weeks. The suspect is of acute right hind limb SL desmitis. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
In longitudinal scanning the SL presents a hypo-anechoic area starting from 
zone 2B until zone 3B. In transverse scanning the lesion occupies the 60% of the 
whole thickness of the ligament. 
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Diagnosis: severe desmitis of the right hind limb SL and lateral branch. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 1471000/µl 
 WBCs count: 25800/µl 
 Whole blood counts: PLT 147000/µl and WBCs 8300/µl 
Platelets had ten times fold concentration and WBCs concentrated of 3 times. 
Clinical course: the horse was kept in stable for two weeks and then started a 
rehabilitation protocol. After 4 months the pathology relapsed in the same area. 
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Case #5: Horse 0100034644 
Breed: Standardbred 
Sex: male 
Age: 10 y. o. 
Activity: trot races 
Anamnesis: the horse is referred for a three weeks old lameness of the right 
hind limb. A hot swelling is appreciated at palpation at the palmar aspect of the 
metatarsus. 
Examination and ultrasound: the lameness and the swelling are present at the 
time of clinical examination (lameness 2/5 degree). 
A hypo-echoic area is visible at the insertion of the medial branch of the right 
hind limb SL. In transverse section the score is 2/3. Misalignment of fibers is 
evaluated in longitudinal scanning and scored 2/3. 
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Diagnosis: right hind limb SL medial branch desmitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 1105000/µl 
 WBCs count: 18500/µl 
 Whole blood counts: PLT 154000/µl and WBCs 8730/µl 
Platelets had a seven times fold concentration and WBCs were little more than 
doubled. 
Clinical course: the horse followed a rehabilitation protocol for 2 months. He 
competed for almost 6 months and was then retired due to the lack of results and 
a relapse of the pathology. Never got back to competition again. 
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Case #6: Horse 0100034657 
Breed: Standardbred 
Sex: male 
Age: 2 y. o. 
Activity: trot races 
Anamnesis: the horse is referred for acute lameness of the left forelimb. A hot, 
painful swelling is visible on the palmar aspect of the correspondent metacarpus. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
An anechoic area of the SDFT is visible in zone 2A. The transverse section 
shows it occupies almost the 50% of the total thickness of the tendon. In 
longitudinal scanning a lack or severe misalignment of fibers (2/3) is visible in 
the same area with swelling of the surrounding tissues. 
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Diagnosis: left forelimb acute SDFT tendonitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 1597000/µl 
 WBCs count: 25700/µl 
 Whole blood counts: PLT 154000/µl and WBCs 8600/µl 
Platelets had a ten times fold concentration and WBCs increased of three times. 
Clinical course: the horse was subjected to a personalized rehabilitation 
protocol: 2 months of stall rest and 2 months of training with increasing 
intensity. He was submitted to ultrasound controls that showed no alteration of 
the area. The horse got back to competition at a higher level than before without 
needing any other pharmacological treatment. 
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Case #7: Horse 0100034670 
Breed: Standardbred 
Sex: male 
Age: 7 y. o. 
Activity: trot races 
Anamnesis: the horse is referred for a two weeks old lameness of the left hind 
limb. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (lameness 2/5 degree). 
An anechoic area (almost 50% of the thickness of the ligament in transverse 
section) is visible at the insertion of the medial branch of the left hind limb SL. 
The whole branch is swollen and edematous. 
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Diagnosis: left hind limb SL medial branch desmitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 970000/µl 
 WBCs count: 20800/µl 
 Whole blood counts: PLT 125000/µl and WBCs 6500/µl 
Platelets had an eight times fold concentration and WBCs were thrice as many. 
Clinical course: the horse followed a rehabilitation protocol with one month of 
stall rest and then let to paddock, with 15 days of simple walks and then 
reintroduction to increasing training. The returned to his previous level of 
training in 4 months. He competed for some months and was then retired due to 
the lack of results and a relapse of the pathology. Never got back to competition 
again. 
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Case #8: Horse 0100034904 
Breed: Italian saddle 
Sex: gelding 
Age: 5 y. o. 
Activity: jumping 
Anamnesis: the horse is referred for right hind limb lameness from a couple of 
weeks. A SL desmitis was suspected. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
The SL of the right hind limb has uneven echostructure with misalignment 
scored 2/3 in zones 2A-3B. 
 
 
 
 
 
 
 
Diagnosis: right hind limb SL desmitis. 
Therapy: ultrasound guided intralesional injection of PRP. 
PRP features: 
The counts were unavailable for a failure of the blood counter. 
Clinical course: the horse followed a personalized rehabilitation schedule. Two 
months after the injection the ultrasound control showed an improvement of the 
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echographic appearance of the ligament. The following control (4 months after 
treatment) showed a SL almost normal. After one year the horse presented a 
lameness in the same hind limb and was submitted to fasciotomy. The 
ultrasound controls after that relieved a complete restore of the tissue despite the 
horse has now a vice of dragging the tip at gait. 
 
 
 
 
 
 
 
 
      One year post-op control. 
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Case #9: Horse 0100034919 
Breed: English Warmblood 
Sex: gelding 
Age: 11 y. o. 
Activity: jumping 
Anamnesis: the horse is referred for a left forelimb hot, painful swelling in the 
proximal palmar aspect of the metacarpus from a couple of weeks. Lameness is 
present and scored 3/5. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (3/5 degree). 
At ultrasound examination the SL is increased in thickness starting from the 
zone 2B. The medial branch is quite swollen too. Both structures show a severe 
architectural inhomogeneity. 
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Diagnosis: left forelimb SL and medial branch desmitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 248000/µl 
 WBCs count: 2080/µl 
 Whole blood counts: PLT 122000/µl and WBCs 6340/µl 
Platelets were only doubled and WBCs halved. 
Clinical course: the horse was allowed two weeks of stable rest and then started 
the rehabilitation protocol. Two months after the injection the body of the SL 
didn‘t show any alteration. The medial branch was still increased in volume and 
presenting some hypo-anechoic areas in transvers scanning. 
A second injection of PRP in the medial branch was performed. PRP was 
remade to obtain a better product than the first one. 
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PRP features: 
 Platelet count: 1354000/µl 
 WBCs count: 14200/µl 
 Whole blood counts: PLT 122000/µl and WBCs 9400/µl 
Platelets were concentrated 11 times and WBCs didn‘t even double. 
Clinical course: five months after the second injection the horse was examined 
and the synovial pouches felt uniformly increased in volume at palpation. The 
swelling was not either hot nor painful. The ultrasound examination showed a 
good alignment of the fibers of the SL. The medial branch appeared slightly 
increased in volume with a mild alteration of the echo-structure in transverse 
section (score 1/3) while the alignment in longitudinal scan is normal. 
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Case #10: Horse 0200003582 
Breed: English Warmblood 
Sex: gelding 
Age: 5 y. o. 
Activity: gallop races 
Anamnesis: the horse is referred for a right forelimb lameness from a few 
weeks. A hot, painful swelling is visible on the palmar aspect of the 
correspondent metacarpus. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
The ultrasound examination showed both in longitudinal and in transverse 
section the presence of various hypo-anechoic areas extending from 1A to 2B 
and occupying from the 30% to the 60% of the thickness of the SDFT. 
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Diagnosis: right forelimb severe SDFT tendonitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 1043000/µl 
 WBCs count: 34000/µl 
 Whole blood counts: PLT 55700/µl and WBCs 3200/µl 
Platelets had almost a twenty times fold concentration and WBCs increased of 
ten times. 
Clinical course: the horse was subjected to a personalized rehabilitation 
protocol. He got back to racing after about six months and was then retired for 
recurrent lameness. The lesions he reported may be considered in the pool of 
pathologies that actually are relapses of the original one. 
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Case #11: Horse 0100035160 
Breed: Oldenburg 
Sex: female 
Age: 23 y. o. 
Activity: country riding 
Anamnesis: the horse is referred for recurrent lameness of the left forelimb. A 
hot, consistent, slightly painful swelling is visible on the palmar aspect of the 
correspondent metacarpus. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (4/5 degree). 
Multiple, severe lesions of the SDFT are visible from the zone 1Bthrough zone 
3A. The series of large anechoic area are visible both in transverse and 
longitudinal scanning. A severe misalignment of fibers and completely uneven 
pattern is presented through the whole length of the lesion. 
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Diagnosis: left forelimb acute SDFT tendonitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 312000/µl 
 WBCs count: 1240/µl 
 Whole blood counts: PLTs 68900/µl and WBCs 7200/µl 
Platelets had almost a five times increase while WBCs increased were six times 
less. 
Clinical course: the horse was subjected to a rehabilitation protocol after a 
period of stable rest. After six months the horse was able to get back to mild 
activity but was never reused as before also due to her age.  
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Case #12: Horse 0200003343 
Breed: Standardbred 
Sex: female 
Age: 3 y. o. 
Activity: trot races 
Anamnesis: the horse is referred for acute lameness of the left forelimb. A mild 
warm swelling is visible on the palmar aspect of the correspondent metacarpus. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
In longitudinal scanning the portion 1B-2A of the SDFT is presenting a hypo-
echoic area about 32mm
2
 wide. Alignment of fibers is scored 2/3. 
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Diagnosis: left forelimb acute SDFT tendonitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Whole blood counts: PLTs 119000/µl and WBCs 4700/µl 
Due to a tilt of the blood counter the PRP count could not be performed. 
Clinical course: the horse was subjected to rehabilitation protocol for almost six 
months with a workload of increasing intensity. The protocol was quite close to 
the one suggested. The horse got back to competition at the same level than 
before without needing any other pharmacological treatment. 
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Case #13: Horse 0100035131 
Breed: Dutch Saddle 
Sex: gelding 
Age: 10 y. o. 
Activity: jumper 
Anamnesis: the horse is referred for chronic lameness of the left forelimb. From 
one year the horse is suffering of SL recurrent desmitis. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (1/5 degree). 
A hypo-echoic area of the SL is visible at its proximal insertion and in zone 2B. 
The transverse and longitudinal sections show a consistent edema and 
misalignment of fibers (1/3) is visible in the same and the surrounding areas. 
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Diagnosis: left forelimb recurrent SL desmitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
       Fasciotomy and neurectomy of the deep branch of the left ulnar nerve. 
PRP features: 
 Platelet count: 735000/µl 
 WBCs count: 4570/µl 
 Whole blood counts: PLTs 129000/µl and WBCs 7400/µl 
Platelets had almost a six times fold and WBCs almost halved. 
Clinical course: the horse was subjected to a personalized rehabilitation 
protocol: 1 months of stall rest and a 5 minutes walk per day. He then followed a 
regular training with increasing intensity. He was submitted to ultrasound 
controls that showed improvement of the appearance of the area. The horse got 
back to competition at a higher level than before with sporadic need for rest 
from training.  
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Case #14: Horse 0200003378 
Breed: Italian Saddle 
Sex: gelding 
Age: 10 y. o. 
Activity: jumper 
Anamnesis: the horse is referred for acute lameness (1/5) of the left forelimb. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (1/5 degree). 
The transverse scan of the SDFT shows a hypo-echoic area at the lateral edge of 
the tendon 3mm thick, in the region 1B-2A. The alignment of fibers is scored 
1/3. 
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Diagnosis: left forelimb acute SDFT tendonitis. 
Therapy: the horse was brought back for stable rest. Less than three weeks later 
he was submitted again to ultrasound control and the lesion had become 7 mm 
wide and the alignment scored 2/3. An ultrasound guided intra-lesional injection 
of PRP was then decided and the pathology recorded as chronic SDFT 
tendonitis. 
PRP features: 
No platelet count was available due to a break of the blood counter. 
Clinical course: the horse was subjected to a rehabilitation protocol and 
followed by the referring veterinarian. After about eight months he got back to 
competition at a lower level. 
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Case #15: Horse 0100034835 
Breed: Italian Saddle 
Sex: gelding 
Age: 4 y. o. 
Activity: jumper 
Anamnesis: the horse is referred for a suspect of right forelimb SDFT 
tendonitis. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
An anechoic area of the SDFT is visible in zone 2A. The transverse section 
shows it occupies almost the 50% of the total thickness of the tendon. In 
longitudinal scanning a sever misalignment of fibers (2/3) is visible in the same 
and the surrounding areas. 
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Diagnosis: left forelimb acute SDFT tendonitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 1597000/µl 
 WBCs count: 25700/µl 
 Whole blood counts: PLT 154000/µl and WBCs 8600/µl 
Platelets had a ten times fold concentration and WBCs increased of three times. 
Clinical course: the horse was subjected to a personalized rehabilitation 
protocol: 2 months of stall rest and 4 months of training with increasing 
intensity. The referring veterinarian refers a period of almost three weeks of 
severe, acute inflammation of the area after injection requiring further 
pharmacological treatments. The horse recovered but competed at lower level 
than before. Afterwards (more than 12 months) he was stopped for orthopedic 
problems of unknown nature. 
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Case #16: Horse 0200003069 
Breed: Quarter Horse 
Sex: gelding 
Age: 5 y. o. 
Activity: saddle/jumping 
Anamnesis: the horse is referred for the acute comparison of a hot swelling on 
the palmar aspect of the left forelimb associated to lameness (3/5) from one 
week. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
The transverse scan of the SDFT shows a hypo-echoic area (scored 2/3) in the 
zones from 1B to 2B, with the worst aspect in 2A. In this zone the CSA of the 
lesion is about 50 mm
2 
wide over the 120mm
2
 of the whole tendon thickness. 
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Diagnosis: left forelimb acute SDFT tendonitis. 
Therapy: ultrasound guided intralesional injection of PRP 
PRP features: 
No platelet count was available due to a break of the blood counter. 
Clinical course: the horse was subjected to rehabilitation protocol and followed 
by the referring veterinarian. After about six months he got back to competition 
at a lower level. 
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Case #17: Horse 0200003067 
Breed: Camargue 
Sex: female 
Age: 14 y. o. 
Activity: saddle/jumping 
Anamnesis: the horse is referred for chronic lameness (1/5) of the left hind 
limb. The suspect is a SL lesion. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (3/5 degree). 
The transverse scan of the SL shows a small round anechoic area within the 
thickness of the ligament in zone 3B. In longitudinal scanning the lesion appears 
fusiform and extended through the whole zone. Misalignment of fibers and 
general edema is visible in zone 1A too. 
 
 
 
 
 
 
 
 
 
 
 
151 
  
Diagnosis: left hind limb chronic SL desmitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 579000/µl 
 WBCs count: 4230/µl 
 Whole blood counts: PLTs 128000/µl and WBCs 5890/µl 
Platelets had almost a four times fold and WBCs decreased of 2/5. 
Clinical course: the horse was subjected to 1 months of stall rest and then let in 
a paddock with 5 minutes walk per day. After two months the horse was still 
lame and came back for ultrasound control. At the time an ossification of the SL 
was detected in correspondence of the distal extremity of the IV metatarsal 
bone, previously fractured and in way of bony rearrangement. The owner was 
recommended for one month of stable rest with light walks starting two weeks 
later to prevent adhesions and reintroduction to work with a very light schedule. 
The horse recovered completely in 9 months.  
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Case #18: Horse 0200003333 
Breed: Italian Saddle 
Sex: female 
Age: 11 y. o. 
Activity: jumping 
Anamnesis: the horse is referred for acute lameness (3/5) of the left forelimb. 
The horse had trained for a jumping competition few days before. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
The ultrasound examination showed an ICL increased in volume in zones 1B-
2A, with inhomogenous pattern and a central hypo-echoic area. 
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Diagnosis: left forelimb acute ICL desmitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 951000/µl 
 WBCs count: 11000/µl 
 Whole blood counts: PLTs 107000/µl and WBCs 6100/µl 
Platelets had about a nine times fold and WBCs doubled. 
Clinical course: the horse was subjected to the standard rehabilitation protocol 
and got back to competition at a lower level after four months. She competed 
well for a couple of months and was brought back to clinic for lameness of the 
right forelimb seven months after the first injury. 
She was submitted to lameness investigation (lameness score 2/5) and 
ultrasound examination. The SDFT at this time presented an elliptic hypo-echoic 
area in the zone 2B-3A, scored 2/3, covering an area of 28mm
2
 in transverse 
scanning. In longitudinal scanning the lesion was 40mm long and scored 2/3. 
The diagnosis was of a sub-acute lesion of the right forelimb SDFT. The horse 
was treated with frozen PRP injection and submitted to rehabilitation protocol 
again. She got back to competition at the same level as before. 
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Case #19: Horse 0200003517 
Breed: Italian Saddle 
Sex: female 
Age: 9 y. o. 
Activity: saddle/jumping 
Anamnesis: the horse is referred for gait impairment of both forelimbs. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
The ultrasound examination of the left forelimb revealed in transverse scan the 
presence of an anechoic area in the medial portion of the SDFT in zone 1A 
(score 2/3); in longitudinal scanning the alignment of fibers was scored 2/3. In 
the right forelimb both in longitudinal and transversal scanning a hypo-echoic 
area was evident in the mid-body of the SL, having CSA of 30% of the whole 
thickness of the ligament. 
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Diagnosis: left forelimb SDFT tendonitis and right forelimb SL desmitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 842000/µl 
 WBCs count: 17100/µl 
 Whole blood counts: PLTs 115000/µl and WBCs 7800/µl 
Platelets had a seven times fold and WBCs increased 2.5 times. 
Clinical course: the horse was subjected to 1 months of stall rest and then let in 
a paddock with 5 minutes walk per day. After two months the horse back for 
ultrasound control and a second injection of PRP was performed in the right 
forelimb SL. The appearance of the left SDFT was in way of recovery with a 
better alignment of fibers. The horse was subjected to standardized rehabilitation 
protocol and got back to activity at a lower level in six months. 
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Case #20: Horse 0200003498 
Breed: English Warmblood 
Sex: male 
Age: 9 y. o. 
Activity: gallop races 
Anamnesis: the horse is referred for acute lameness of the left forelimb. 
Examination and ultrasound: the lameness is present at the time of clinical 
examination (2/5 degree). 
The ultrasound examination of the left forelimb revealed in transverse scan the 
presence of an anechoic area in the mid-body of the SL (score 2/3); in 
longitudinal scanning the alignment of fibers was scored 2/3. 
Diagnosis: left forelimb SL acute desmitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 1362000/µl 
 WBCs count: 24200/µl 
 Whole blood counts: PLTs 130000/µl and WBCs 8100/µl 
Platelets had a ten times fold and WBCs increased 3 times. 
Clinical course: the horse was subjected to a rehabilitation protocol quite 
similar to the one proposed. After two months the horse had an ultrasound 
control and the veterinarian was cautiously optimist because of the appearance 
of the lesion. The horse got back to activity after six more months (8 months 
after treatment) at the same level of competition as before. No relapse was 
reported within the 12 months follow-up. 
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Case #21: Horse 0200003429 
Breed: Arabian 
Sex: male 
Age: 3 y. o. 
Activity: trekking/cross country 
Anamnesis: the horse is referred for a traumatic almost complete (90% of 
thickness) severing of the right forelimb SDFT. 
Examination and ultrasound: the horse was obviously not subjected to 
lameness investigation. A tenorraphy was performed and the limb was casted in 
flexed position for one month. Afterwards the cast was removed, and the 
ultrasound and PRP were performed. The examination revealed both in 
transverse and longitudinal scan the formation of some tissue alternated to large 
anechoic areas, in sort of a beehive fashion in some points, from zone 2A 
through 3B. 
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Diagnosis: right forelimb chronic SDFT tendonitis. 
Therapy: ultrasound guided intra-lesional injection of PRP. 
PRP features: 
 Platelet count: 1506000/µl 
 WBCs count: 27200/µl 
 Whole blood counts: PLTs 166000/µl and WBCs 10200/µl 
Platelets had a nine times fold and WBCs increased almost three times. 
Clinical course: after the first month with the cast the horse was applied a 
corrective shoeing with high heels and a soft simple bandage to protect the digit. 
The horse started the suggested rehabilitation protocol with the exception that 
the trotting was not introduced for four months. The horse was allowed to a 
really small paddock though, four months after injury. 
Seven months after injury the horse was able to trot regularly and one year after 
injury he was ridden again. He showed some gait impairment but the gross 
appearance of the limb was quite normal. The ultrasound controls showed a 
surprising normality both of fiber echogenicity and alignment. 
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DISCUSSION 
 
 
 
Results for this study will only be reported as descriptive considerations 
throughout the discussion. The choice is due to the impossibility to perform a 
significant statistic analysis for the issues already discussed and later on taken 
again into consideration. This can be considered a limit to the research but is 
the most correct way to treat the reported data: producing numbers out of non-
standardized information is considered both scientifically and mathematically 
incorrect. 
 
Lesions of tendons and ligaments in horses are a consistent problem both for the 
frequency and for the difficulty to achieve complete healing and functional 
recovery. Therapeutic treatments so far proposed haven‘t yet brought to 
completely satisfactory outcomes. Traditional treatments lead to the formation 
of a scar which is stronger than the original tissue and quite less elastic. This is 
the reason why often lesions relapse in the areas surrounding the scar. Relapses 
are still nowadays a majorly occurring problem. 
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The use of PRP for the treatment of tendons and ligaments lesions in horses has 
been proposed on the spite of the enthusiasm of its use in human medicine 
(Anitua et al., 2003; Marx et al., 2004; Everts et al., 2006), with the aim of 
obtaining tissue regeneration and not only simple reparation of tendons and 
ligaments. 
Aim of this study was to try to evaluate clinically the efficacy of the intra-
lesional injection of PRP for tendons and ligaments lesions in the limb of horses, 
after having the demonstration of its effectiveness on the healing of other tissues 
(Carter et al., 2003; Spadari et al., 2006). 
In this study another issue was the designing of a protocol for the preparation of 
the PRP that would be effective, quick, easy, repeatable and cheap. Meanwhile, 
limit since the start of the project, it was known that the greatest limit would be 
the impossibility to quantify the growth factors; the evaluation of its quality 
could only be made on the platelet count which is not significant itself, even 
though in human medicine it has been shown that it can be considered 
appropriate for concentrations of 1.000.000 platelets/mm
3
 (Van Den Dolder et 
al., 2006). 
The method for the preparation of the PRP that was finally set up is a manual 
method based on the double centrifugation system. Compared to other methods 
(buffy coat, apheresis, filtration after apheresis) or to the use of commercial kits 
this was the cheapest, the easiest, and the faster to be used in the reality of our 
clinic. 
The biggest issue though to design a research project on this subject was the 
impossibility to perform a programmed study in regards of the number of cases, 
the asset of interventions, the control of the follow up and outcome. The clinical 
trial isn‘t for sure the best method to perform research as the subjects, 
spontaneously afferent clinical cases, present a huge variability of specimen. 
The lesions differed for site, time of occurrence, gravity and extensions; the 
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rehabilitation protocols were quite uncontrollable, the availability of owners to 
cooperate in the post-op hard to quest, the assessment of ultrasound controls 
difficult to standardize. Thus the efficacy of the treatment couldn‘t be straightly 
related to any standard variable, such as the method of preparation or the type of 
lesion, but only on the outcome of the treatment itself. 
Furthermore the clinical trial lacks of experimental studies on standardized 
models to compare the effectiveness of the treatment to other therapeutic 
options. 
The setting up of the method passed through some trials which would not avoid, 
in any case, the need for an adjustment of the time of centrifugation (first 
centrifugation) to obtain a good separation of the hematic fractions. The 
evaluation was based on the observation of the relative proportion of the 
fractions compared to that of the blood count. A difficulty of separation of the 
fractions is usually to be imputed to a higher viscosity of the blood (thus to its 
rheological characteristics) or the impairment between the quantity of 
anticoagulant and coagulation properties of the blood. 
The method itself usually produced a concentration of the platelets of 5-10 times 
fold, while WBC averagely increased 2-3 times. It thus turned out to be quite 
effective as the concentration of platelets was averagely above the seven times 
fold. 
In this study the PRP was injected without activation. Many studies have been 
performed using PRP activated with calcium, thrombin, or through freezing 
(Anitua et al., 2004; Borzini and Mazzucco, 2005; Everts et al., 2006; Del Bue 
et al., 2007; Zimmermann et al., 2008). The general lack of literature about its 
use in tendons and ligaments in horses though led to the choice to use it as it is, 
given the fact of its instability. The activation through freezing would have been 
the other option of choice but it doesn‘t allow the treatment to be performed 
right after the diagnosis. 
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The management of the horse in the post-operative period and the rehabilitation 
protocol have a crucial role in the final outcome. It was decided and followed 
either by the owner or the referring veterinarian with impossibility to 
modification on our behalf. Similarly, the impossibility to have periodical 
standardized ultrasound controls has limited the ability to adjust the schedule 
properly. To optimize the rehabilitation period ultrasound controls should be 
ideally performed every 2-3 months at the most (Smith, 2008). 
Besides the clinical and ultrasonographic evaluation, the soundness of a sport 
horse is mainly based on the level of competition, the number of start-ups and 
the money gained in competition. Thus in this study the outcome was evaluated 
on the basis of the return to activity, the level of competition and the time of 
rehabilitation. The presence of clinical symptoms and the need for other 
treatment were investigated and reported when the owner would let the 
information. The difficulties in obtaining more certain data about the events that 
follow the intervention are not only to be imputed to unavailability or bad will of 
owners. Transportation and clinical handling in general is both an expense and a 
stress for the horse, sometimes requiring sedation for the containment; 
furthermore the practitioners having the horses in cure must be trusted as 
competent colleagues. The possibility to have a mobile unit to follow the horses 
would help in the future to have more thorough and consistent follow-ups. 
Given the difficulties above reported but considering the outcomes, the 
treatment should be considered quite effective: 5/22 treatments (one horse 
treated for two completely different lesions) had a straightforward negative 
outcome, with 1/22 treatment with unknown exitus. This number is above any 
other reported in literature, but many considerations will follow on its 
trustfulness. 
In this study the follow up is usually up to twelve months after injury. This 
choice was made to be able to consider equally the majority of the cases, 
otherwise the horse treated in the last year couldn‘t be inserted in the study. 
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Some horses have relapsed before the first year had passed and were considered 
as clearly negative outcomes. They can be ascribed either to a bad or too short 
rehabilitation protocol or to the ineffectiveness of the treatment itself. It is to be 
considered though that the majority of relapses occurred was in those horses 
(mainly trotter horses) that are erroneously pushed to get back to activity too 
soon. There is the general belief that the so called ―regenerative treatments‖ 
would speed up the healing and a gradual reintroduction to training is 
superfluous. It is instead true that healing can be speed up and improved in the 
quality of the tissue produced but the proper reintroduction of a horse to sport 
activity is still considered to be happening in a lapse of time between 9 and 18 
months, depending on the severity of the lesion. Even the smallest lesions (only 
echographically evident) should be let at least six months to heal (Smith, 2008): 
these conditions are incompatible with the reality of the horse racing world. 
Relapses we know about also occurred in the first year after treatment, yet we 
know that in 5/21 more cases the sport activity has been afterwards performed at 
a lower level. The sum of the ten cases with the two with uncertain outcome 
(12/22) pretty much resembles the results presented by other studies. 
The platelet count of the PRPs applied in the relapsing cases was quite 
consistent, and this would support the thesis that the correlation between platelet 
count and outcome is not straight forward. The platelet concentrate that was 
actually used is a platelet-leucocyte rich plasma and the clinical effects depend 
on the combination of both PLTs and WBCs about which too little is still known 
(Everts et al., 2007). 
One issue the debate is still opened on is on the number of applications of PRP 
to be performed. Only in one case it was decided to perform a double injection, 
while all other horses have been treated once, or in two different sites. The 
consideration made was that pulling exogenous material into an healing tissue 
may alter the arrangement of the fibrils in shaping and potentially jeopardize the 
regular processes of healing that may be ongoing. 
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Some cases have been considered with positive outcome even if the horse had to 
interrupt the sport activity before the one year had passed because of other 
causes. The horses that got back to activity with good result within one year 
after treatment have had quite different rehabilitation periods and protocols but 
differ widely for platelet count. The good result can also be attributed to the 
young age of subjects (case 2, having also a relatively low platelet count), which 
certainly helps the regeneration of the tissue, whereas older horses may have 
good results because their activity is much less pushed (cases 11, 17). 
For the horses whose long term destination is unknown the outcome was 
considered either positive or negative up to the time it is known. This choice 
was made on the basis that the cases in which the ultrasound control where 
performed at two and four months after treatment already showed an almost 
total normality in their appearance where a scar was not even visible. The 
tendon or the ligament thus seem to reacquire their original aspect. 
The positive follow up after one year doesn‘t mean a relapse may occur later on 
(see case 7). Thus the positive outcomes so far investigated may turn out in 
negatives on a longer term, as it is shown in a study similar to this. In that case, 
the results reported for the first two years after treatment were excellent but after 
three years the results were worse than after 24 months (Waselau et al., 2008). 
Arguelles and colleagues have had positive results with the application of PRP 
in tenodesmic lesions but the cases have been likewise followed for only one 
year after treatment (Arguelles et al., 2008). 
Similarly the application of mesenchymal stem cells, having had positive results 
on the regeneration of tendons and ligaments (Crovace et al., 2007; Fortier and 
Smith, 2008) still doesn‘t guarantee long term results. Having similar results 
between PRP and MSCs the advantages of PRP must be considered as it is less 
invasive, cheapest, quickest and much easier to be applied (Fortier et al., 2008). 
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CONCLUSIONS 
 
 
 
The results here reported do not allow to assess that the intralesional application 
of PRP is an effective therapy in course of tendons‘ and ligaments‘ lesions in 
sport horses. 
The variables interfering in the study were definitely too many to give certain 
results, and the small number of horses, even with some data about, only allow 
to produce some hypotheses. The ultrasonographic improvements of the tissues 
and to possibility for at least 14 horses out of 21 to return to activity can only 
make us suppose the treatment for effective for the purpose. It must be 
remembered though that later than 12 months relapses stay unknown. 
PRP must be recognized as an excellent therapeutic option among the many, as 
it is quick, cheap, repeatable, and with no complications so far reported. 
In the future effort should be put in the directions to improve the separation 
method to have only platelets in the product and eventually have them purified, 
so that they could be used on a horse different from the donor. The other aim is 
the quantification of GFs and how effective they can be in relation to the time of 
usage. Obviously the timing of multiple injections is to be addressed too. 
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The periodic ultrasonographic evaluation is a good mean of investigation and 
may demonstrate the improvements in the speed and the quality of the healing. 
This results seem to be quite far to be standardized though until research studies 
on live horses, other than clinical trials, will be allowed on larger numbers. 
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